POLYCOM INC, 10-Q filed on 10/30/2014
Quarterly Report
Document and Entity Information
9 Months Ended
Sep. 30, 2014
Oct. 24, 2014
Document And Entity Information [Abstract]
 
 
Document Type
10-Q 
 
Amendment Flag
false 
 
Document Period End Date
Sep. 30, 2014 
 
Document Fiscal Year Focus
2014 
 
Document Fiscal Period Focus
Q3 
 
Trading Symbol
PLCM 
 
Entity Registrant Name
POLYCOM INC 
 
Entity Central Index Key
0001010552 
 
Current Fiscal Year End Date
--12-31 
 
Entity Filer Category
Large Accelerated Filer 
 
Entity Common Stock, Shares Outstanding
 
136,482,766 
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets
 
 
Cash and cash equivalents
$ 406,323 
$ 392,629 
Short-term investments
151,069 
134,684 
Trade receivables, net of allowance for doubtful accounts of $3,105 and $2,827 at September 30, 2014 and December 31, 2013, respectively
181,447 
183,369 
Inventories
97,949 
103,309 
Deferred taxes
37,547 
37,085 
Prepaid expenses and other current assets
63,214 
50,352 
Total current assets
937,549 
901,428 
Property and equipment, net
106,081 
115,157 
Long-term investments
85,599 
56,372 
Goodwill
559,287 
559,460 
Purchased intangibles, net
27,734 
37,458 
Deferred taxes
47,416 
51,398 
Other assets
28,062 
27,757 
Total assets
1,791,728 
1,749,030 
Current liabilities
 
 
Accounts payable
94,478 
84,640 
Accrued payroll and related liabilities
34,785 
40,162 
Taxes payable
4,226 
5,389 
Deferred revenue
175,307 
172,408 
Current portion of long-term debt
6,250 
6,250 
Other accrued liabilities
78,479 
77,744 
Total current liabilities
393,525 
386,593 
Non-current liabilities
 
 
Long-term deferred revenue
82,101 
87,467 
Taxes payable
11,745 
12,419 
Deferred taxes
117 
149 
Long-term debt
237,500 
242,188 
Other non-current liabilities
47,651 
43,849 
Total non-current liabilities
379,114 
386,072 
Total liabilities
772,639 
772,665 
Stockholders' equity
 
 
Common stock, $0.0005 par value; Authorized: 350,000,000 shares; Issued and outstanding: 136,480,882 shares at September 30, 2014 and 135,159,966 shares at December 31, 2013
67 
68 
Additional paid-in capital
1,157,308 
1,104,273 
Accumulated deficit
(143,488)
(132,348)
Accumulated other comprehensive income
5,202 
4,372 
Total stockholders' equity
1,019,089 
976,365 
Total liabilities and stockholders' equity
$ 1,791,728 
$ 1,749,030 
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Statement Of Financial Position [Abstract]
 
 
Trade receivables, allowance for doubtful accounts
$ 3,105 
$ 2,827 
Common stock, par value
$ 0.0005 
$ 0.0005 
Common stock, shares authorized
350,000,000 
350,000,000 
Common stock, shares issued
136,480,882 
135,159,966 
Common stock, shares outstanding
136,480,882 
135,159,966 
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues:
 
 
 
 
Product revenues
$ 240,059 
$ 242,515 
$ 708,133 
$ 740,066 
Service revenues
95,627 
93,946 
288,096 
280,381 
Total revenues
335,686 
336,461 
996,229 
1,020,447 
Cost of revenues:
 
 
 
 
Cost of product revenues
101,399 
102,830 
296,745 
309,994 
Cost of service revenues
37,617 
38,587 
115,607 
114,714 
Total cost of revenues
139,016 
141,417 
412,352 
424,708 
Gross profit
196,670 
195,044 
583,877 
595,739 
Operating expenses:
 
 
 
 
Sales and marketing
97,953 
107,292 
289,757 
325,663 
Research and development
51,024 
54,220 
148,202 
164,782 
General and administrative
25,746 
28,468 
74,175 
76,461 
Amortization of purchased intangibles
2,435 
2,487 
7,363 
7,535 
Restructuring costs
(2,631)
24,887 
36,887 
34,639 
Litigation reserves and payments
3,130 
 
3,130 
 
Transaction-related costs
 
39 
156 
3,411 
Total operating expenses
177,657 
217,393 
559,670 
612,491 
Operating income (loss)
19,013 
(22,349)
24,207 
(16,752)
Interest and other income (expense), net:
 
 
 
 
Interest expense
(1,470)
(850)
(4,404)
(1,736)
Other income (expense)
1,285 
(784)
1,828 
(1,041)
Interest and other income (expense), net
(185)
(1,634)
(2,576)
(2,777)
Income (loss) from continuing operations before provision for (benefit from) income taxes
18,828 
(23,983)
21,631 
(19,529)
Provision for (benefit from) income taxes
1,817 
(5)
54 
(2,963)
Net income (loss) from continuing operations
17,011 
(23,978)
21,577 
(16,566)
Gain from sale of discontinued operations, net of taxes
 
 
459 
Net income (loss)
$ 17,011 
$ (23,978)
$ 21,577 
$ (16,107)
Basic net income (loss) per share:
 
 
 
 
Net income (loss) per share from continuing operations
$ 0.12 
$ (0.14)
$ 0.16 
$ (0.10)
Gain per share from sale of discontinued operations, net of taxes
$ 0 
$ 0 
$ 0 
$ 0 
Basic net income (loss) per share
$ 0.12 
$ (0.14)
$ 0.16 
$ (0.09)
Diluted net income (loss) per share:
 
 
 
 
Net income (loss) per share from continuing operations
$ 0.12 
$ (0.14)
$ 0.15 
$ (0.10)
Gain per share from sale of discontinued operations, net of taxes
$ 0 
$ 0 
$ 0 
$ 0 
Diluted net income (loss) per share
$ 0.12 
$ (0.14)
$ 0.15 
$ (0.09)
Number of shares used in computation of net income (loss) per share:
 
 
 
 
Basic
136,606 
170,310 
137,139 
172,644 
Diluted
142,176 
170,310 
142,406 
172,644 
Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Net income (loss)
$ 17,011 
$ (23,978)
$ 21,577 
$ (16,107)
Other comprehensive income (loss), net of tax:
 
 
 
 
Foreign currency translation adjustments
179 
86 
(907)
579 
Unrealized gains/losses on investments:
 
 
 
 
Unrealized holding gains (losses) arising during the period
(43)
96 
(43)
10 
Net gains/losses reclassified into earnings
(7)
(5)
(9)
66 
Net unrealized gains (losses) on investments
(50)
91 
(52)
76 
Unrealized gains/losses on hedging securities:
 
 
 
 
Unrealized hedge gains (losses) arising during the period
2,573 
(570)
2,574 
1,793 
Net unrealized gains (losses) on hedging securities
1,231 
(1,800)
1,789 
(563)
Other comprehensive income (loss)
1,360 
(1,623)
830 
92 
Comprehensive income (loss)
18,371 
(25,601)
22,407 
(16,015)
Product revenues
 
 
 
 
Unrealized gains/losses on hedging securities:
 
 
 
 
Net gains/losses reclassified into earnings for hedges
(1,222)
(716)
3,052 
(1,190)
Expense
 
 
 
 
Unrealized gains/losses on hedging securities:
 
 
 
 
Net gains/losses reclassified into earnings for hedges
$ (120)
$ (514)
$ (3,837)
$ (1,166)
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:
 
 
Net income (loss)
$ 21,577 
$ (16,107)
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
Depreciation and amortization
43,201 
49,607 
Amortization of purchased intangibles
9,724 
11,335 
Amortization of capitalized software development costs for products to be sold
1,269 
47 
Amortization of debt issuance costs
400 
52 
Amortization of discounts and premiums on investments, net
1,440 
1,323 
Provision for doubtful accounts
600 
 
Write-down of excess and obsolete inventories
3,682 
5,625 
Stock-based compensation expense
34,178 
53,300 
Excess tax benefits from stock-based compensation expense
(2,595)
(780)
Loss on disposal of property and equipment
4,987 
3,658 
Net gain on sale of discontinued operations
(459)
Changes in assets and liabilities, net of effects of acquisitions:
 
 
Trade receivables
1,432 
21,857 
Inventories
1,678 
(13,346)
Deferred taxes
(7,705)
2,058 
Prepaid expenses and other assets
(11,974)
(18,915)
Accounts payable
8,867 
(1,118)
Taxes payable
7,178 
(4,006)
Other accrued liabilities and deferred revenue
(3,290)
24,661 
Net cash provided by operating activities
114,649 
118,792 
Cash flows from investing activities:
 
 
Purchases of property and equipment
(36,847)
(40,704)
Capitalized software development costs for products to be sold
(3,069)
(1,089)
Purchases of investments
(220,575)
(202,268)
Proceeds from sales of investments
40,709 
21,802 
Proceeds from maturities of investments
132,753 
185,634 
Net cash received from sale of discontinued operations
 
556 
Net cash paid in purchase acquisitions
 
(7,974)
Net cash used in investing activities
(87,029)
(44,043)
Cash flows from financing activities:
 
 
Proceeds from issuance of common stock under employee option and stock purchase plans
23,407 
23,326 
Proceeds from debt, net of debt issuance costs
 
247,582 
Payments on debt
(4,688)
 
Purchase and retirement of common stock
(35,240)
(110,816)
Excess tax benefits from stock-based compensation expense
2,595 
780 
Net cash provided by (used in) financing activities
(13,926)
160,872 
Net increase in cash and cash equivalents
13,694 
235,621 
Cash and cash equivalents, beginning of period
392,629 
477,073 
Cash and cash equivalents, end of period
$ 406,323 
$ 712,694 
Basis of Presentation
Basis of Presentation

1. BASIS OF PRESENTATION

The accompanying unaudited financial statements, consisting of the condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of operations for the three and nine months ended September 30, 2014 and 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2014 and 2013, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013, have been prepared in accordance with accounting principles generally accepted in the United States of America in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. In addition, the condensed consolidated balance sheet at December 31, 2013 has been derived from the audited consolidated financial statements as of that date. Accordingly, these condensed consolidated financial statements do not include all of the information and footnotes typically found in the audited consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K of Polycom, Inc. and its subsidiaries (the “Company”). In the opinion of management, the accompanying unaudited financial statements have been prepared on a basis consistent with the Company’s December 31, 2013 audited financial statements and all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement have been included. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates and operating results for the three and nine months ended September 30, 2014 and are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.

Revision of Prior Period Financial Statements

During the three months ended December 31, 2013, the Company discovered an error that impacted the Company’s previously issued interim and annual consolidated statements of cash flows. The error was related to the net amortization of discounts and premiums on investments not being properly reported, which resulted in understated cash flows provided by operating activities and understated or overstated cash provided by or used in investing activities in the first three quarters of 2013 and full fiscal years 2012 and 2011.

In evaluating whether the Company’s previously issued condensed consolidated statements of cash flows were materially misstated, the Company considered the guidance in ASC Topic 250, Accounting Changes and Error Corrections, ASC Topic 250-10-S99-1, Assessing Materiality and ASC Topic 250-10-S99-2, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements. The Company concluded that this error was not material to any of the prior reporting periods, and therefore, amendments of previously filed reports were not required. However, the consolidated statements of cash flow correction would impact comparisons to prior periods. As such, the revision for the correction is reflected in the financial information of the applicable prior periods and will be reflected in future filings containing such financial information.

The following table sets forth a summary of the revision to the condensed consolidated statement of cash flows for the following period (in thousands):

 

 

Nine Months Ended September 30, 2013

 

 

As Previously

Reported

 

 

Adjustment

 

 

As Revised

 

Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

 

Amortization of discounts and premiums on investments, net

$

 

 

$

1,323

 

 

$

1,323

 

Net cash provided by operating activities

$

117,469

 

 

$

1,323

 

 

$

118,792

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

$

(200,945

)

 

$

(1,323

)

 

$

(202,268

)

Net cash used in investing activities

$

(42,720

)

 

$

(1,323

)

 

$

(44,043

)

 

 

Recent Accounting Pronouncements
Recent Accounting Pronouncements

 

2. RECENT ACCOUNTING PRONOUNCEMENTS

In August 2014, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update related to the disclosures around going concern. The new standard provides guidance around management’s responsibility to evaluate whether there are conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The new standard is effective for the annual periods and interim periods within those annual periods beginning after December 15, 2016. Early application is permitted. The Company does not expect any impact on the adoption of this standard on its consolidated financial statements.

In May 2014, the FASB issued an accounting standard update which provides companies with a single model for use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance, including industry-specific revenue guidance. The core principle of the model is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The guidance is effective for annual reporting periods beginning after December 15, 2016. Early adoption is not permitted. The guidance permits companies to either apply the requirements retrospectively to all prior periods presented, or apply the requirements in the year of adoption, through a cumulative adjustment. The Company has not yet selected a transition method nor has it determined the impact of adoption on its consolidated financial statements.

In July 2013, the FASB issued an accounting standard update which clarifies that an unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. In situations where a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction or the tax law of the jurisdiction does not require, and the entity does not intend to use the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The guidance is effective prospectively for reporting periods beginning after December 15, 2013. The Company adopted the guidance in the three months ended March 31, 2014, and such adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Discontinued Operations
Discontinued Operations

3. DISCONTINUED OPERATIONS

On December 4, 2012, the Company completed the disposition of the net assets of its enterprise wireless voice solutions (“EWS”) business to Mobile Devices Holdings, LLC, a Delaware limited liability corporation. The Company received cash consideration of approximately $50.7 million, resulting in a gain on sale of the discontinued operations, net of taxes, of $35.4 million, as reflected in its consolidated financial statements for the year ended December 31, 2012. In the nine months ended September 30, 2013, the Company recorded an additional gain on sale of discontinued operations, net of taxes, of approximately $0.5 million as a result of the final net working capital adjustment in accordance with the purchase agreement. Additional cash consideration of up to $37.5 million is payable to Polycom over the next three years subject to certain conditions, including meeting certain agreed-upon EBITDA-based milestones for the fiscal years ending December 31, 2014, 2015 and 2016. These conditions were not met for the fiscal year ended December 31, 2013. Such additional cash consideration will be accounted for as a gain on sale of discontinued operations, net of taxes, when it is realized or realizable. For the nine months ended September 30, 2014, there was no realized gain on sale of discontinued operations.

Business Combinations
Business Combinations

4. BUSINESS COMBINATIONS

On March 1, 2013 the Company completed its acquisition of certain assets of Sentri, Inc. (“Sentri”), a privately-held services company with expertise in Microsoft technologies, for approximately $8.0 million in cash, net of approximately $0.4 million cash released from an escrow account in September 2013, as a result of a net working capital adjustment. The total purchase price was allocated to the net tangible and intangible assets based upon their fair values at March 1, 2013, with the excess amount recorded as goodwill. The goodwill is primarily attributable to the expertise of former Sentri employees in Microsoft technologies and expected synergies from the combined company. The Company has included the financial results of Sentri in its condensed consolidated financial statements from the date of acquisition. Pro forma and actual results of operations of the acquisition were not material to the Company’s condensed consolidated financial statements.

Accounts Receivable Financing
Accounts Receivable Financing

 

5. ACCOUNTS RECEIVABLE FINANCING

In 2012, the Company launched a customer financing program and entered into a financing agreement (the “Financing Agreement”) with an unrelated third party financing company. The program offers with distributors and resellers direct or indirect financing on their purchases of the Company’s products and services. In return, the Company agrees to pay the financing company a fee based on a pre-defined percentage of the transaction amount financed. In certain instances, these financing arrangements result in a transfer of our receivables, without recourse, to the financing company. If the transaction meets the applicable criteria under Accounting Standards Codification (“ASC”) 860 and is accounted for as a sale of financial assets, the accounts receivable are excluded from the balance sheet upon the third party financing company’s payment remittance to the Company. In certain legal jurisdictions, the arrangement fees that involve maintenance services or products bundled with maintenance at one price do not qualify as a sale of financial assets in accordance with the authoritative guidance. Accordingly, accounts receivable related to these arrangements are accounted for as a secured borrowing in accordance with ASC 860, and the Company records a liability for any cash received, while maintaining the associated accounts receivable balance until the distributor or reseller remits payment to the third-party financing company.

In the three months ended September 30, 2014, total transactions entered pursuant to the terms of the Financing Agreement were approximately $48.8 million, of which $29.4 million was related to the transfer of the financial assets arrangement. In the three months ended September 30, 2013, total transactions entered were approximately $32.6 million, of which $27.9 million was related to the transfer of the financial assets arrangement. In the nine months ended September 30, 2014, total transactions entered pursuant to the terms of the Financing Agreement were approximately $132.6 million, of which $98.1 million was related to the transfer of the financial assets arrangement. In the nine months ended September 30, 2013, total transactions entered were approximately $83.3 million, of which $73.1 million was related to the transfer of the financial assets arrangement. The financing of these receivables accelerated the collection of the Company’s cash and reduced its credit exposure. The amount due from the financing company as of September 30, 2014 and December 31, 2013 was approximately $23.7 million and $22.9 million, respectively, of which $16.5 million and $21.6 million, respectively, was related to the accounts receivable transferred, and is included in “Trade receivables” in the Company’s condensed consolidated balance sheets. Fees incurred pursuant to the Financing Agreement were approximately $0.7 million and $0.5 million for the three months ended September 30, 2014 and 2013, respectively, and were approximately $1.8 million and $1.2 million for the nine months ended September 30, 2014 and 2013, respectively. Those fees were recorded as reductions to revenues.

Goodwill, Purchased Intangibles, and Software Development Costs
Goodwill, Purchased Intangibles, and Software Development Costs

6. GOODWILL, PURCHASED INTANGIBLES, AND SOFTWARE DEVELOPMENT COSTS

Goodwill

The following table presents the changes to the Company’s goodwill by segment during the nine months ended September 30, 2014 (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

Balance at December 31, 2013

$

308,159

 

 

$

101,882

 

 

$

149,419

 

 

$

559,460

 

Foreign currency translation

 

 

 

 

 

 

 

(173

)

 

 

(173

)

Balance at September, 30, 2014

$

308,159

 

 

$

101,882

 

 

$

149,246

 

 

$

559,287

 

 

 

Purchased Intangible Assets and Software Development Costs

The following table presents details of the Company’s total purchased intangible assets and capitalized software development costs for products to be sold as of the following periods (in thousands):

 

 

September 30, 2014

 

 

December 31, 2013

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

Core and developed technology

$

81,178

 

 

$

(79,256

)

 

$

1,922

 

 

$

81,178

 

 

$

(76,952

)

 

$

4,226

 

Customer and partner relationships

 

79,525

 

 

 

(55,749

)

 

 

23,776

 

 

 

79,525

 

 

 

(48,941

)

 

 

30,584

 

Non-compete agreements

 

1,800

 

 

 

(950

)

 

 

850

 

 

 

1,800

 

 

 

(500

)

 

 

1,300

 

Trade name

 

3,400

 

 

 

(3,194

)

 

 

206

 

 

 

3,400

 

 

 

(3,089

)

 

 

311

 

Other

 

4,462

 

 

 

(4,400

)

 

 

62

 

 

 

4,462

 

 

 

(4,343

)

 

 

119

 

Finite-lived intangible assets

 

170,365

 

 

 

(143,549

)

 

 

26,816

 

 

 

170,365

 

 

 

(133,825

)

 

 

36,540

 

Indefinite-lived trade name

 

918

 

 

 

 

 

 

918

 

 

 

918

 

 

 

 

 

 

918

 

Total acquired intangible assets

$

171,283

 

 

$

(143,549

)

 

$

27,734

 

 

$

171,283

 

 

$

(133,825

)

 

$

37,458

 

Capitalized software development costs for products to be sold

$

5,575

 

 

$

(1,465

)

 

$

4,110

 

 

$

2,365

 

 

$

(196

)

 

$

2,169

 

 

Purchased intangibles include a purchased trade name of $0.9 million with an indefinite life as the Company expects to generate cash flows related to this asset indefinitely. Consequently, this trade name is not amortized but is reviewed for impairment annually or sooner when indicators of potential impairment exist.

The following table summarizes the amortization expenses recorded in the following periods (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Amortization of purchased intangibles in revenues

$

19

 

 

$

19

 

 

$

57

 

 

$

56

 

Amortization of purchased intangibles in cost of product revenues

 

732

 

 

 

1,248

 

 

 

2,304

 

 

 

3,744

 

Amortization of purchased intangibles in operating expenses

 

2,435

 

 

 

2,487

 

 

 

7,363

 

 

 

7,535

 

Total amortization expenses of purchased intangibles

$

3,186

 

 

$

3,754

 

 

$

9,724

 

 

$

11,335

 

 

Amortization of purchased intangibles is not allocated to the Company’s segments.

The estimated future amortization expense as of September 30, 2014 is as follows (in thousands):

 

Year ending December 31,

 

Amount

 

Remainder of 2014

 

$

3,167

 

2015

 

 

10,495

 

2016

 

 

8,484

 

2017

 

 

4,670

 

2018

 

 

 

Total

 

$

26,816

 

In the nine months ended September 30, 2014 and 2013, the Company capitalized approximately $3.2 million and $1.2 million of software development costs, respectively, for internally developed software products to be marketed and sold to customers after the point that technological feasibility has been reached and before the products are available for general release. The capitalized costs are being amortized over the estimated product useful life, generally three years, beginning when the products are available for general release. Management expects that the capitalized software development costs are recoverable from future gross profits generated by these products and services.

Restructuring Costs
Restructuring Costs

7. RESTRUCTURING COSTS

The Company recorded a $2.6 million credit in restructuring costs, primarily due to changes in assumptions used in our facilities-related restructuring reserve estimate, and $24.9 million of charges during the three months ended September 30, 2014 and 2013, respectively, and $36.9 million and $34.6 million in restructuring charges during the nine months ended September 30, 2014 and 2013, respectively. Pursuant to the announcement in January 2014, management completed certain actions designed to better align expenses to the Company’s revenue and gross margin profile and position the Company for improved operating performance. These actions included the elimination of approximately six percent of the global workforce and reduction or elimination of certain leased facilities. The Company has recorded approximately $33.1 million in restructuring costs (net of adjustments related to the assumptions used in the estimate of the related liabilities reserves) as of September 30, 2014 in connection with these actions announced in January 2014 and does not expect any remaining charges to be material.

The following table summarizes the changes in the Company’s restructuring reserves during the nine months ended September 30, 2014 (in thousands):

 

 

Severance/Other

 

 

Facilities

 

 

Total

 

Balance at December 31, 2013

$

1,143

 

 

$

33,786

 

 

$

34,929

 

Additions to the reserve, net

 

11,106

 

 

 

23,991

 

 

 

35,097

 

Interest accretion

 

 

 

 

1,790

 

 

 

1,790

 

Non-cash write-offs

 

 

 

 

(2,576

)

 

 

(2,576

)

Cash payments and other usage

 

(10,790

)

 

 

(15,624

)

 

 

(26,414

)

Balance at September 30, 2014

$

1,459

 

 

$

41,367

 

 

$

42,826

 

 

As of September 30, 2014, the restructuring reserve was primarily comprised of facilities-related liabilities. The Company calculated the fair value of its facilities-related liabilities based on the discounted future lease payments less sublease assumptions. This fair value measurement is classified as a Level 3 measurement under ASC 820. The key assumptions used in the valuation model include discount rates, cash flow projections, and estimated sublease income. These assumptions involve significant judgment, are based on management’s estimate of current and forecasted market conditions and are sensitive and susceptible to change.

Balance Sheet Details
Balance Sheet Details

8. BALANCE SHEET DETAILS

Trade receivables, net consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Gross accounts receivables

$

224,871

 

 

$

225,134

 

Returns and related reserves

 

(40,319

)

 

 

(38,938

)

Allowance for doubtful accounts

 

(3,105

)

 

 

(2,827

)

Total

$

181,447

 

 

$

183,369

 

 

Inventories consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Raw materials

$

2,657

 

 

$

2,740

 

Work in process

 

1,018

 

 

 

840

 

Finished goods

 

94,274

 

 

 

99,729

 

Total

$

97,949

 

 

$

103,309

 

 

 

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Non-trade receivables

$

5,056

 

 

$

9,251

 

Prepaid expenses

 

42,548

 

 

 

31,164

 

Derivative assets

 

10,454

 

 

 

6,748

 

Other current assets

 

5,156

 

 

 

3,189

 

Total

$

63,214

 

 

$

50,352

 

 

Deferred revenue consists of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Short-term:

 

 

 

 

 

 

 

Service

$

173,367

 

 

$

170,701

 

Product

 

112

 

 

 

307

 

License

 

1,828

 

 

 

1,400

 

Total

$

175,307

 

 

$

172,408

 

Long-term:

 

 

 

 

 

 

 

Service

$

78,495

 

 

$

83,092

 

Product

 

 

 

 

 

License

 

3,606

 

 

 

4,375

 

Total

$

82,101

 

 

$

87,467

 

 

Changes in the deferred service revenue are as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Balance at beginning of period

$

252,995

 

 

$

252,091

 

 

$

253,793

 

 

$

241,773

 

Additions to deferred service revenue

 

85,246

 

 

 

87,993

 

 

 

255,705

 

 

 

268,392

 

Amortization of deferred service revenue

 

(86,379

)

 

 

(86,114

)

 

 

(257,636

)

 

 

(256,195

)

Balance at end of period

$

251,862

 

 

$

253,970

 

 

$

251,862

 

 

$

253,970

 

 

Other accrued liabilities consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Accrued expenses

$

27,222

 

 

$

22,515

 

Accrued co-op expenses

 

4,068

 

 

 

4,629

 

Restructuring reserves

 

15,344

 

 

 

11,238

 

Warranty obligations

 

10,766

 

 

 

9,475

 

Derivative liabilities

 

5,262

 

 

 

6,780

 

Employee stock purchase plan withholdings

 

5,129

 

 

 

10,883

 

Other accrued liabilities

 

10,688

 

 

 

12,224

 

Total

$

78,479

 

 

$

77,744

 

 

Changes in the warranty obligation are as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Balance at beginning of period

$

10,350

 

 

$

9,686

 

 

$

9,475

 

 

$

10,475

 

Accruals for warranties issued during the period

 

3,846

 

 

 

4,295

 

 

 

11,977

 

 

 

12,407

 

Actual charges against warranty reserve during the period

 

(3,430

)

 

 

(4,270

)

 

 

(10,686

)

 

 

(13,171

)

Balance at end of period

$

10,766

 

 

$

9,711

 

 

$

10,766

 

 

$

9,711

 

 

Commitments and Contingencies
Commitments and Contingencies

9. COMMITMENTS AND CONTINGENCIES

Litigation and SEC Investigation

From time to time, the Company is involved in claims and legal proceedings that arise in the ordinary course of business. The Company expects that the number and significance of these matters will increase as business expands. In particular, the Company faces an increasing number of patent and other intellectual property claims as the number of products and competitors in Polycom’s industry grows and the functionality of video, voice, data and web conferencing products overlap. Any claims or proceedings against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require the Company to enter into royalty or licensing agreements which, if required, may not be available on terms favorable to the Company or at all. If management believes that a loss arising from these matters is probable and can be reasonably estimated, the Company will record a reserve for the loss. As additional information becomes available, any potential liability related to these matters is assessed and the estimates revised. Based on currently available information, management does not believe that the ultimate outcomes of these unresolved matters, individually and in the aggregate, are likely to have a material adverse effect on the Company’s financial position, liquidity or results of operations. However, litigation is subject to inherent uncertainties, and the Company’s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position and results of operations or liquidity for the period in which the unfavorable outcome occurs or becomes probable, and potentially in future periods.

During the three months ended September 30, 2014, the Company recorded $3.1 million in litigation reserves and payments related to on-going litigation matters, which have not yet been settled.

On July 23, 2013, the Company announced that Andrew M. Miller had resigned from the positions of Chief Executive Officer and President of Polycom and from Polycom’s Board of Directors. The Company disclosed that Mr. Miller’s resignation came after a review by the Audit Committee of certain expense submissions by Mr. Miller, where the Audit Committee found certain irregularities in the submissions, for which Mr. Miller had accepted responsibility. Specifically, the Audit Committee determined that Mr. Miller improperly submitted personal expenses to Polycom for payment as business expenses and, in doing so, submitted to Polycom false information about the nature and purpose of expenses.

SEC Investigation. As previously disclosed, the Company has been cooperating with the Enforcement Staff of the Securities and Exchange Commission (“SEC”) in connection with its investigation focused on Mr. Miller's expenses and his resignation. After discussions with the Enforcement Staff, the Company recently made an offer of settlement to resolve the matter, which is subject to the SEC’s approval.  The proposed settlement would be entered into by Polycom without admitting or denying the SEC’s findings and will resolve alleged violations of certain provisions of the Securities Exchange Act of 1934 and related rules.  Under the terms of the proposed settlement, the Company would pay $750,000 in a civil penalty, which has been fully reserved for in our financial statements, and agree not to commit or cause any violations of certain provisions of the Securities Exchange Act of 1934 and related rules.  There is no assurance that the proposal will be approved by the SEC.

Class Action Lawsuit. On July 26, 2013, a purported shareholder class action, initially captioned Neal v. Polycom Inc., et al., Case No. 3:13-cv-03476-SC, and presently captioned Nathanson v. Polycom, Inc., et al., Case No. 3:13-cv-03476-SC, was filed in the United States District Court for the Northern District of California against the Company and certain of its current and former officers and directors. On December 13, 2013, the Court appointed a lead plaintiff and approved lead and liaison counsel. On February 24, 2014, the lead plaintiff filed a first amended complaint. The amended complaint alleges that, between January 20, 2011 and July 23, 2013, the Company issued materially false and misleading statements or failed to disclose information regarding the Company’s business, operational and compliance policies, including with respect to its former Chief Executive Officer’s expense submissions and the Company’s internal controls. The lawsuit further alleges that the Company’s financial statements were materially false and misleading. The amended complaint alleges violations of the federal securities laws and seeks unspecified compensatory damages and other relief. The defendants filed motions to dismiss the amended complaint. At this time, we are unable to estimate any range of reasonably possible loss relating to the securities class action.

Derivative Lawsuits. On August 21, 2013 and October 16, 2013, two purported shareholder derivative suits, captioned Saraceni v. Miller, et al., Case No. 5:13-cv-03880, and Donnelly v. Miller, et al., Case No. 5:13-cv-04810, respectively, were filed in the United States District Court for the Northern District of California against certain of the Company’s current and former officers and directors. On October 31, 2013, these two federal derivative actions were consolidated into In re Polycom, Inc. Derivative Litigation, Lead Case No. 3:13-cv-03880. Plaintiffs filed an amended complaint on April 4, 2014. The defendants filed motions to dismiss the amended complaint.

On November 22, 2013 and December 13, 2013, two purported shareholder derivative suits, captioned Ware v. Miller, et al., Case No. 1-13-cv-256608, and Clem v. Miller, et al., Case No. 1-13-cv-257664, respectively, were filed in the Superior Court of California, County of Santa Clara, against certain of the Company’s current and former officers and directors. On January 31, 2014, these two California state derivative actions were consolidated into In re Polycom, Inc. Derivative Shareholder Litigation, Lead Case No. 1-13-cv-256608. The Court has stayed the California state derivative litigation pending resolution of both the federal derivative lawsuit and the federal securities class action.

The Federal and California state consolidated derivative lawsuits purport to assert claims on behalf of the Company, which is named as a nominal defendant in the actions. The complaints allege claims for breach of fiduciary duty, unjust enrichment, and corporate waste, and allege certain defendants failed to maintain adequate internal controls and issued, or authorized the issuance of, materially false and misleading statements, including with respect to the Company’s former Chief Executive Officer’s expense submissions and the Company’s internal controls. The complaints further allege that certain defendants approved an unjustified separation agreement and caused the Company to repurchase its own stock at artificially inflated prices. The complaints seek unspecified compensatory damages, corporate governance reforms, and other relief. At this time, we are unable to estimate any range of reasonably possible loss relating to the derivative actions.

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, the Company has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was serving, at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification obligations is unlimited; however, the Company has a director and officer insurance policy that mitigates the Company’s exposure and enables the Company to recover a portion of any future amounts paid. As a result of the Company’s insurance policy coverage, the Company believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in the Company’s industry, as provided for in local law in the U.S. and other jurisdictions, the Company’s standard contracts provide remedies to its customers, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of its products. From time to time, the Company indemnifies customers against combinations of loss, expense, or liability arising from various trigger events related to the sale and the use of its products and services. In addition, from time to time, the Company also provides protection to customers against claims related to undiscovered liabilities, additional product liability or environmental obligations.

Debt
Debt

10. DEBT

On September 13, 2013, the Company entered into a Credit Agreement (the “Credit Agreement”) among the Company, certain of its subsidiaries from time to time party thereto as guarantors, the lenders from time to time party thereto and Morgan Stanley Senior Funding, Inc., as Administrative Agent and Collateral Agent. The Credit Agreement provides for a $250.0 million term loan (the “Term Loan”) maturing on September 13, 2018 (the “Maturity Date”) and bears interest at the Company’s option at either a base rate plus a spread of 0.50% to 1.00%, or a reserve adjusted LIBOR rate plus a spread of 1.50% to 2.00% based on the Company’s consolidated leverage ratio for the preceding four fiscal quarters.

The Company entered into the Credit Agreement in conjunction with and for purposes of funding purchases of the Company’s common stock pursuant to a $250.0 million modified “Dutch Auction” self-tender offer announced in September 2013. See Note 14 for further details. Interest is due and payable in arrears quarterly for loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of loans bearing interest at the reserve adjusted LIBOR rate. The Term Loan is payable in quarterly installments of principal equal to $1.6 million which began on December 31, 2013, with the remaining outstanding principal amount of the Term Loan being due and payable on the Maturity Date. The Company may prepay the Term Loan, in whole or in part, at any time without premium or penalty. Amounts repaid or prepaid may not be reborrowed. The Term Loan is secured by substantially all the assets of certain domestic subsidiaries of the Company, subject to certain exceptions and limitations. The Company is also obligated to pay other customary closing fees, arrangement fees, and administration fees for a credit facility of this size and type. Total debt issuance costs incurred on the Term Loan were approximately $2.7 million and were recorded in “Prepaid expenses and other current assets” and “Other assets” in the Company’s condensed consolidated balance sheet and are being amortized over the life of the Term Loan.

The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company’s and its subsidiaries’ ability to, among other things, grant liens, make investments, incur indebtedness, merge or consolidate, dispose of assets, make acquisitions, pay dividends or make distributions, repurchase stock, enter into transactions with affiliates and enter into restrictive agreements, in each case subject to customary exceptions for a credit facility of this size and type. The Company is also required to maintain compliance with a consolidated fixed charge coverage ratio and a consolidated secured leverage ratio. The Company was in compliance with these covenants as of September 30, 2014.

The Credit Agreement includes customary events of default that include, among other things, non-payment defaults, covenant defaults, inaccuracy of representations and warranties, cross default to material indebtedness, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults and a change of control default. The occurrence of an event of default could result in the acceleration of the obligations under the Credit Agreement. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Credit Agreement at a per annum rate equal to 2.00% above the applicable interest rate for any overdue principal and 2.00% above the rate applicable for base rate loans for any other overdue amounts.

At September 30, 2014, the weighted average interest rate on the Term Loan was 1.99%, the accrued interest on the Term Loan was $0.1 million, and the current and noncurrent portion of the outstanding Term Loan was $6.3 million and $237.5 million, respectively.

The following table sets forth total interest expense recognized on the Term Loan (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Contractual interest expense

$

1,233

 

 

$

305

 

 

$

3,687

 

 

$

305

 

Amortization of debt issuance costs

 

133

 

 

 

52

 

 

 

400

 

 

 

52

 

Total

$

1,366

 

 

$

357

 

 

$

4,087

 

 

$

357

 

 

Investments
Investments

11. INVESTMENTS

The Company had cash and cash equivalents of $406.3 million and $392.6 million at September 30, 2014 and December 31, 2013, respectively. Cash and cash equivalents consist of cash in banks, as well as highly liquid investments in money market funds, time deposits, savings accounts, commercial paper, U.S. government and agency securities, municipal securities and corporate debt securities. At September 30, 2014, the Company’s long-term investments had contractual maturities of one to two years.

In addition, the Company has short-term and long-term investments in debt securities which are summarized as follows (in thousands):

 

 

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

Balances at September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

28,888

 

 

$

23

 

 

$

 

 

$

28,911

 

U.S. government agency securities

 

39,246

 

 

 

19

 

 

 

(1

)

 

 

39,264

 

Non-U.S. government securities

 

6,804

 

 

 

4

 

 

 

 

 

 

6,808

 

Corporate debt securities

 

76,088

 

 

 

21

 

 

 

(23

)

 

 

76,086

 

Total investments - short-term

$

151,026

 

 

$

67

 

 

$

(24

)

 

$

151,069

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

28,544

 

 

$

14

 

 

$

(2

)

 

$

28,556

 

U.S. government agency securities

 

30,664

 

 

 

5

 

 

 

(28

)

 

 

30,641

 

Non-U.S. government securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

26,422

 

 

 

4

 

 

 

(24

)

 

 

26,402

 

Total investments - long-term

$

85,630

 

 

$

23

 

 

$

(54

)

 

$

85,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,792

 

 

$

9

 

 

$

 

 

$

19,801

 

U.S. government agency securities

 

38,388

 

 

 

16

 

 

 

(3

)

 

 

38,401

 

Non-U.S. government securities

 

13,734

 

 

 

10

 

 

 

 

 

 

13,744

 

Corporate debt securities

 

62,720

 

 

 

22

 

 

 

(4

)

 

 

62,738

 

Total investments - short-term

$

134,634

 

 

$

57

 

 

$

(7

)

 

$

134,684

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

12,252

 

 

$

8

 

 

$

 

 

$

12,260

 

U.S. government agency securities

 

30,627

 

 

 

12

 

 

 

(3

)

 

 

30,636

 

Non-U.S. government securities

 

2,305

 

 

 

4

 

 

 

 

 

 

2,309

 

Corporate debt securities

 

11,152

 

 

 

15

 

 

 

 

 

 

11,167

 

Total investments - long-term

$

56,336

 

 

$

39

 

 

$

(3

)

 

$

56,372

 

 

Unrealized Losses

The following table summarizes the fair value and gross unrealized losses of the Company’s investments, including those that are categorized as cash equivalents, with unrealized losses aggregated by type of investment instrument and length of time that individual securities have been in a continuous unrealized loss position as of September 30, 2014 and December 31, 2013 (in thousands):

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

5,478

 

 

$

(2

)

 

$

 

 

$

 

 

$

5,478

 

 

$

(2

)

U.S. government agency securities

 

19,964

 

 

 

(29

)

 

 

 

 

 

 

 

 

19,964

 

 

 

(29

)

Corporate debt securities

 

54,662

 

 

 

(47

)

 

 

 

 

 

 

 

 

54,662

 

 

 

(47

)

Total investments

$

80,104

 

 

$

(78

)

 

$

 

 

$

 

 

$

80,104

 

 

$

(78

)

December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

$

5,533

 

 

$

(6

)

 

$

 

 

$

 

 

$

5,533

 

 

$

(6

)

Corporate debt securities

 

9,837

 

 

 

(3

)

 

 

1,504

 

 

 

(1

)

 

 

11,341

 

 

 

(4

)

Total investments

$

15,370

 

 

$

(9

)

 

$

1,504

 

 

$

(1

)

 

$

16,874

 

 

$

(10

)

 

The Company reviews the individual securities in its portfolio to determine whether a decline in a security’s fair value below the amortized cost basis is other-than-temporary. If the decline in fair value is considered to be other-than-temporary, the cost basis of the individual security is written down to its fair value as a new cost basis and the amount of the write-down is accounted for as a realized loss and included in earnings. During the nine months ended September 30, 2014 and 2013, the Company determined that there were no investments in its portfolio that were other-than temporarily impaired.

Private Company Investments

The Company has made various strategic investments in private companies. The private company investments are carried at cost and written down to their estimated net realizable value when indications exist that these investments have been impaired. The Company did not record such impairment charges during the nine months ended September 30, 2014 and 2013. The cost of these investments at both September 30, 2014 and December 31, 2013 was $2.0 million, and has been recorded in “Other assets” in the Company’s condensed consolidated balance sheets.

Fair Value Measurements
Fair Value Measurements

12. FAIR VALUE MEASUREMENTS

Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As the basis for considering such assumptions, a three-tier value hierarchy prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions. This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, the Company measures certain financial assets and liabilities at fair value, including its marketable securities and foreign currency contracts.

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using inputs such as quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. The types of instruments valued based on quoted market prices for identical assets in active markets include money market funds and are generally classified within Level 1 of the fair value hierarchy.

The types of instruments valued based on other observable inputs include U.S. Treasury securities and other government agencies, corporate bonds and commercial paper. Such instruments are generally classified within Level 2 of the fair value hierarchy. Level 2 instruments are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. There have been no transfers between Level 1 and Level 2 during the three and nine months ended September 30, 2014 and 2013. The Company does not hold any investments classified as Level 3 as of September 30, 2014 and December 31, 2013.

As of September 30, 2014, the Company’s fixed income available-for-sale securities include U.S. Treasury obligations and other government agency instruments (51%), corporate bonds (31%), commercial paper (13%), non-U.S. Government securities (3%), and money market funds (2%). Included in available-for-sale securities is approximately $15.3 million of cash equivalents, which consist of investments with original maturities of three months or less and include money market funds.

The principal market where the Company executes its foreign currency contracts is the retail market in an over-the-counter environment with a relatively high level of price transparency. The market participants and the Company’s counterparties are large money center banks and regional banks. The Company’s foreign currency contracts valuation inputs are based on quoted prices and quoted pricing intervals from public data sources such as spot rates, interest rate differentials and credit default rates, which do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.

The Company’s Term Loan under its Credit Agreement is classified within Level 2 instruments as the borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to the Company for debt with similar terms and maturities. See Note 10. The Company has elected not to record its Term Loan at fair value, but has measured it at fair value for the disclosure purpose. At September 30, 2014 and December 31, 2013, the estimated fair value of the Term Loan was approximately $235.5 million and $247.5 million, respectively, based on observable market inputs.

The fair value of the Company’s marketable securities and foreign currency contracts was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements at

September 30, 2014 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

251,969

 

 

$

6,052

 

 

$

245,917

 

Foreign currency forward contracts (b)

 

$

10,454

 

 

$

 

 

$

10,454

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

5,262

 

 

$

 

 

$

5,262

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at

December 31, 2013 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

211,151

 

 

$

17,596

 

 

$

193,555

 

Foreign currency forward contracts (b)

 

$

6,748

 

 

$

 

 

$

6,748

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,780

 

 

$

 

 

$

6,780

 

 

(a)

Included in cash and cash equivalents, and short and long-term investments in the Company’s condensed consolidated balance sheets.

(b)

Included in short-term derivative assets as prepaid expenses and other current assets in the Company’s condensed consolidated balance sheets.

(c)

Included in short-term derivative liabilities as other accrued liabilities in the Company’s condensed consolidated balance sheets.

The Company’s current accounting policy and practice is not to offset derivative assets and liabilities in its condensed consolidated balance sheets. See Note 13.

Foreign Currency Derivatives
Foreign Currency Derivatives

13. FOREIGN CURRENCY DERIVATIVES

The Company maintains a foreign currency risk management program that is designed to reduce the volatility of the Company’s economic value from the effects of unanticipated currency fluctuations. International operations generate both revenues and costs denominated in foreign currencies. The Company’s policy is to hedge significant foreign currency revenues and costs to improve margin visibility and reduce earnings volatility associated with unexpected changes in currency.

Non-Designated Hedges

The Company hedges its net foreign currency monetary assets and liabilities primarily resulting from foreign currency denominated revenues and expenses with foreign exchange forward contracts to reduce the risk that the Company’s earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments are carried at fair value with changes in the fair value recorded as interest and other income (expense), net. These derivative instruments do not subject the Company to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset remeasurement gains and losses on the hedged assets and liabilities. The Company executes non-designated foreign exchange forward contracts primarily denominated in Euros, British Pounds, Israeli Shekels, Brazilian Reals, Chinese Yuan, Japanese Yen and Mexican Pesos.

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent of the outstanding non-designated hedges at September 30, 2014 (in thousands):

 

 

Original Maturities of 360 Days or Less

 

Original Maturities of Greater than 360 Days

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

Brazilian Real

 

10,508

 

 

$

4,287

 

 

Buy

 

 

 

 

$

 

 

Brazilian Real

 

19,975

 

 

$

8,487

 

 

Sell

 

 

 

 

 

 

 

Chinese Yuan

 

132,129

 

 

$

21,457

 

 

Buy

 

 

 

 

$

 

 

Chinese Yuan

 

128,938

 

 

$

20,724

 

 

Sell

 

 

 

 

$

 

 

Euro

 

21,287

 

 

$

27,031

 

 

Buy

 

 

6,400

 

 

$

8,629

 

 

Buy

Euro

 

50,325

 

 

$

65,702

 

 

Sell

 

 

20,800

 

 

$

28,043

 

 

Sell

British Pound

 

22,223

 

 

$

36,504

 

 

Buy

 

 

6,600

 

 

$

10,551

 

 

Buy

British Pound

 

19,126

 

 

$

31,426

 

 

Sell

 

 

7,800

 

 

$

12,469

 

 

Sell

Israeli Shekel

 

18,043

 

 

$

4,923

 

 

Buy

 

 

30,900

 

 

$

8,706

 

 

Buy

Israeli Shekel

 

41,125

 

 

$

11,305

 

 

Sell

 

 

 

 

$

 

 

Japanese Yen

 

514,868

 

 

$

4,694

 

 

Buy

 

 

 

 

$

 

 

Japanese Yen

 

930,002

 

 

$

8,745

 

 

Sell

 

 

 

 

$

 

 

Mexican Peso

 

14,129

 

 

$

1,052

 

 

Buy

 

 

 

 

$

 

 

Mexican Peso

 

24,673

 

 

$

1,861

 

 

Sell

 

 

 

 

$

 

 

 

 

The following table shows the effect of the Company’s non-designated hedges in the condensed consolidated statements of operations for the following periods (in thousands):

 

Derivatives Not Designated as

Hedging Instruments

 

Location of Gain or (Loss)

Recognized in Income on Derivative

 

Amount of Gain or (Loss)

Recognized in Income on Derivative

 

 

 

 

 

Three Months Ended

 

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

3,991

 

 

$

(1,783

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

4,290

 

 

$

(182

)

 

 

Cash Flow Hedges

The Company’s foreign exchange risk management program objective is to reduce volatility in the Company’s economic value from unanticipated foreign currency fluctuations. The Company designates forward contracts as cash flow hedges of foreign currency revenues and expenses, primarily the Chinese Yuan, Euros, British Pounds and Israeli Shekels. All foreign exchange contracts are carried at fair value on the condensed consolidated balance sheets and the maximum duration of foreign exchange forward contracts does not exceed thirteen months. Speculation is prohibited by policy.

To receive hedge accounting treatment under ASC 815, Derivatives and Hedging, all cash flow hedging relationships are formally designated at hedge inception, and tested both prospectively and retrospectively to ensure the forward contracts are highly effective in offsetting changes to future cash flows on the hedged transactions. The Company records effective spot to spot changes in these cash flow hedges in cumulative other comprehensive income until they are reclassified to revenue, cost of revenue or operating expenses together with the hedged transaction. The time value on forward contracts is excluded from effectiveness testing and recorded to interest and other income (expense), net over the life of the contract together with any ineffective portion of the hedge.

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent of the outstanding cash flow hedges at September 30, 2014 (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Chinese Yuan

 

 

119,271

 

 

$

18,931

 

 

Buy

 

 

 

 

$

 

 

 

Euro

 

 

25,966

 

 

$

34,655

 

 

Buy

 

 

 

 

 

 

 

 

 

Euro

 

 

62,368

 

 

$

83,220

 

 

Sell

 

 

 

 

 

 

 

 

 

British Pound

 

 

21,054

 

 

$

34,737

 

 

Buy

 

 

 

 

 

 

 

 

 

British Pound

 

 

25,028

 

 

$

41,308

 

 

Sell

 

 

 

 

 

 

 

 

 

Israeli Shekel

 

 

82,564

 

 

$

23,359

 

 

Buy

 

 

 

 

 

 

 

 

 

 

The following tables show the effect of the Company’s derivative instruments designated as cash flow hedges in the condensed consolidated statements of operations for the following periods (in thousands):

 

 

 

Gain or (Loss) Recognized in OCI-Effective Portion

 

 

Location of Gain or (Loss) Reclassified from OCI into Income-Effective Portion

 

Gain or (Loss) Reclassified from OCI into Income-Effective Portion

 

 

Location of Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from

Effectiveness Testing

 

Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness

Testing (a)

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

$

2,573

 

 

$

(570

)

 

Product revenues

 

$

1,222

 

 

$

716

 

 

Interest and other income (expense), net

 

$

49

 

 

$

113

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

17

 

 

 

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

(60

)

 

 

34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and

   development

 

 

3

 

 

 

423

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and

   administrative

 

 

160

 

 

 

(33

)

 

 

 

 

 

 

 

 

 

 

 

 

$

2,573

 

 

$

(570

)

 

 

 

$

1,342

 

 

$

1,230

 

 

 

 

$

49

 

 

$

113

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

 

 

Nine Months Ended

 

 

 

 

Nine Months Ended

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

$

2,574

 

 

$

1,793

 

 

Product revenues

 

$

(3,052

)

 

$

1,190

 

 

Interest and other income (expense), net

 

$

(3

)

 

$

273

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

879

 

 

 

138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

1,737

 

 

 

(73

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and

   development

 

 

695

 

 

 

1,075

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and

   administrative

 

 

526

 

 

 

26

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2,574

 

 

$

1,793

 

 

 

 

$

785

 

 

$

2,356

 

 

 

 

$

(3

)

 

$

273

 

 

  

 

(a)There were no gains or losses recognized in income due to ineffectiveness in the periods presented.

As of September 30, 2014, the Company estimated that all values reported in accumulated other comprehensive income (loss) will be reclassified to income within the next twelve months.

In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge would be immediately reclassified to interest and other income (expense), net on the consolidated statements of operations. For the nine months ended September 30, 2014 and 2013, there were no such gains or losses.

The estimates of fair value are based on applicable and commonly quoted prices and prevailing financial market information as of September 30, 2014 and December 31, 2013. See Note 12 for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and derivative liabilities that are measured at fair value in the condensed consolidated financial statements on a recurring basis.

The following table shows the Company’s derivative instruments measured at gross fair value as reflected in the condensed consolidated balance sheets as of the periods presented (in thousands):

 

 

Fair Value of

Derivatives Designated

as Hedge Instruments

 

 

Fair Value of Derivatives

Not Designated as Hedge

Instruments

 

 

September 30,

2014

 

 

December 31,

2013

 

 

September 30,

2014

 

 

December 31,

2013

 

Derivative assets (a):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

5,122

 

 

$

4,457

 

 

$

5,332

 

 

$

2,291

 

Derivative liabilities (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

3,281

 

 

$

4,235

 

 

$

1,981

 

 

$

2,545

 

 

  

 

(a)

All derivative assets are recorded in “Prepaid and other current assets” in the condensed consolidated balance sheets.

(b)

All derivative liabilities are recorded in “Other accrued liabilities” in the condensed consolidated balance sheets.

Offsetting Derivative Assets and Liabilities

The Company has entered into master netting arrangements with each of its derivative counterparties. These arrangements afford the right to net derivative assets against liabilities with the same counterparty. Under certain default provisions, the Company has the right to setoff any other amounts payable to the payee whether or not arising under this agreement. As a result of the netting provisions, the Company’s maximum amount of loss under derivative transactions due to credit risk is limited to the net amounts due from the counterparties under the derivative contracts. Although netting is permitted, it is currently the Company’s policy and practice to record all derivative assets and liabilities on a gross basis in the condensed consolidated balance sheets.

The following table sets forth the offsetting of derivative assets (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

Gross Amounts of Recognized Assets

 

 

Gross Amounts

Offset in the Condensed Consolidated

Balance Sheets

 

 

Net Amounts Of Assets Presented In the Condensed Consolidated Balance Sheets

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

10,454

 

 

$

 

 

$

10,454

 

 

$

(5,259

)

 

$

 

 

$

5,195

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,748

 

 

$

 

 

$

6,748

 

 

$

(5,643

)

 

$

 

 

$

1,105

 

 

 

 

 

The following table sets forth the offsetting of derivative liabilities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

Gross Amounts of Recognized Liabilities

 

 

Gross Amounts

Offset in the Condensed Consolidated

Balance Sheets

 

 

Net Amounts Of Liabilities Presented In the Condensed Consolidated Balance Sheets

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

5,262

 

 

$

 

 

$

5,262

 

 

$

(5,259

)

 

$

 

 

$

3

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,780

 

 

$

 

 

$

6,780

 

 

$

(5,643

)

 

$

 

 

$

1,137

 

 

Stockholders' Equity
Stockholders' Equity

14. STOCKHOLDERS’ EQUITY

Share Repurchase Program

From time to time, the Company’s Board of Directors has approved plans under which the Company may at its discretion purchase shares of its common stock in the open market or via privately negotiated transactions. In July 2014, the Company announced that its Board of Directors had approved a new share repurchase plan (the “2014 repurchase plan”) under which the Company may at its discretion purchase shares in the open market with an aggregate value of up to $200.0 million. The Company expects to execute this new authorization over the next two years and to fund the share repurchases through cash on hand and future cash flow from operations. During the three months ended September 30, 2014, the Company purchased approximately 1.9 million shares of common stock in the open market for $25.0 million. During the six months ended June 30, 2014, the Company did not purchase any shares of common stock in the open market. However, the Company received 1.5 million shares in June 2014 under its accelerated share repurchase program as discussed below. During the three and nine months ended September 30, 2013, the Company purchased approximately 1.7 million and 9.8 million shares of common stock, respectively, in the open market for $17.7 million and $102.3 million of cash, respectively. The purchase price for the shares of the Company’s stock repurchased is recorded as a reduction to stockholders’ equity. The excess of the cost of treasury stock that is retired over the fair value based on the calculated average price in equity is recorded as a charge to retained earnings. As of September 30, 2014, we had a remaining authorization to purchase up to an additional $175.0 million of shares in the open market under the 2014 repurchase plan.

In September 2013, the Company announced that its Board of Directors had authorized the repurchase of $400.0 million, or approximately 20 percent, of the Company’s outstanding common stock (“Return of Capital Program”), through a $250.0 million modified “Dutch Auction” self-tender offer (the “Tender Offer”) and subsequent open market purchases or privately negotiated transactions. The Company funded the program with $150.0 million in cash and its $250.0 million Term Loan (see Note 10).

Modified “Dutch Auction” Self-Tender Offer

The Tender Offer expired on October 30, 2013. The Company accepted for payment an aggregate of 27.4 million shares of its common stock at a purchase price of $10.40 per share, for an aggregate cost of approximately $285.4 million, excluding fees and expenses relating to the Tender Offer. The excess of the purchase price over the fair value on the date the shares were tendered was not material and no charge was recorded in the Company’s consolidated statements of operations. The costs associated with the Tender Offer were accounted for as an adjustment to the stockholders’ equity.

Accelerated Share Repurchase Agreements

On December 4, 2013, the Company entered into separate accelerated share repurchase (“ASR”) agreements with two financial institutions to repurchase an aggregate of $114.6 million of common stock as part of the last phase of the Company’s $400.0 million Return of Capital Program. Under the terms of the ASR agreements, the Company paid an aggregate $114.6 million of cash and received an initial delivery of approximately 8.0 million shares in December 2013. The ASR contracts were settled in June 2014, whereby the Company received an additional 1.5 million shares upon settlement. The aggregate 9.5 million shares ultimately purchased under the ASR program was determined based on the Company’s volume-weighted average stock price (“VWAP”) less an agreed upon discount during the term of the transactions. Total shares repurchased were immediately retired upon delivery and accounted for as a reduction to stockholders’ equity. The costs associated with the ASR transactions were recorded as an adjustment to the stockholders’ equity. Additionally, the Company accounted for the ASR transactions as repurchases of common stock for the purpose of calculating its earnings per share when the shares were received.

Accumulated Other Comprehensive Income

The following table summarizes the changes in accumulated other comprehensive income, net of tax, by component for the nine months ended September 30, 2014 (in thousands). The tax effects were not shown separately, as the impacts were not material.

 

Nine Months Ended September 30, 2014

 

Unrealized

Gains and

Losses on

Cash Flow

Hedges

 

 

Unrealized Gains

and Losses on

Available-for-

Sale Securities

 

 

Foreign Currency

Translation

 

 

Total

 

Balance as of December 31, 2013

 

$

80

 

 

$

73

 

 

$

4,219

 

 

$

4,372

 

Other comprehensive income (loss) before reclassifications

 

 

2,574

 

 

 

(43

)

 

 

(907

)

 

 

1,624

 

Amounts reclassified from accumulated

     other comprehensive income (a)

 

 

(785

)

 

 

(9

)

 

 

 

 

 

(794

)

Net current-period other comprehensive income (loss)

 

 

1,789

 

 

 

(52

)

 

 

(907

)

 

 

830

 

Balance as of September 30, 2014

 

$

1,869

 

 

$

21

 

 

$

3,312

 

 

$

5,202

 

 

 

 

(a)

See Note 13 of Notes to Condensed Consolidated Financial Statements for details of gains and losses, net of taxes, reclassified out of accumulated other comprehensive income into net income related to cash flow hedges and each line item of net income affected by the reclassification. Gains and losses related to available-for-sale securities were reclassified into “Other income (expense)” in the condensed consolidated statement of operations for the nine months ended September 30, 2014, net of taxes.

Stock-Based Compensation
Stock-Based Compensation

15. STOCK-BASED COMPENSATION

The following table summarizes stock-based compensation expense recorded for the periods presented and its allocation within the condensed consolidated statements of operations (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Cost of sales - product

$

668

 

 

$

686

 

 

$

1,828

 

 

$

2,252

 

Cost of sales - service

 

1,102

 

 

 

1,479

 

 

 

3,164

 

 

 

4,600

 

Stock-based compensation expense included in cost of sales

 

1,770

 

 

 

2,165

 

 

 

4,992

 

 

 

6,852

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

4,673

 

 

 

5,889

 

 

 

10,397

 

 

 

19,742

 

Research and development

 

3,203

 

 

 

3,669

 

 

 

7,304

 

 

 

12,578

 

General and administrative

 

5,122

 

 

 

5,479

 

 

 

11,485

 

 

 

14,128

 

Stock-based compensation expense included in operating

     expenses

 

12,998

 

 

 

15,037

 

 

 

29,186

 

 

 

46,448

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases

 

14,768

 

 

 

17,202

 

 

 

34,178

 

 

 

53,300

 

Tax benefit

 

3,016

 

 

 

7,960

 

 

 

6,778

 

 

 

24,663

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases, net of tax

$

11,752

 

 

$

9,242

 

 

$

27,400

 

 

$

28,637

 

 

Stock-based compensation expense is not allocated to segments because it is centrally managed at the corporate level.

Stock Options

There were no stock options granted in the nine months ended September 30, 2014 and 2013.

Performance Shares and Restricted Stock Units

During the nine months ended September 30, 2014 and 2013, the Company granted 659,416 and 1,373,329, respectively, of performance shares to certain employees and executives, at a weighted average fair value of $13.81 and $8.83 per share, respectively. The 2014 and 2013 grants are generally divided evenly over three annual performance periods commencing with calendar year 2014 and 2013, respectively.

During the nine months ended September 30, 2014 and 2013, the Company granted 2,847,979 and 4,571,571, respectively, of restricted stock units at a weighted average fair value of $12.96 and $10.12 per share, respectively.

During the nine months ended September 30, 2014 and 2013, the Company granted non-employee directors 140,000 and 100,000, respectively, of restricted stock units at a weighted average fair value of $12.87 and $11.14 per share, respectively.

Employee Stock Purchase Plan

During the nine months ended September 30, 2014 and 2013, 2,944,069 and 2,904,287 shares were purchased under the Company’s employee stock purchase plan (“ESPP”), respectively. As of September 30, 2014, there were 11,315,067 shares available to be issued under ESPP.

Valuation Assumptions

For purchase rights granted pursuant to the ESPP, the estimated fair value per share of employee stock purchase rights for the two-year offering period commencing on August 1, 2014 ranged from $2.80 to $4.10, compared to the estimated fair value per share from $2.60 to $4.06 for the two-year offering period commencing on August 1, 2013. The estimated fair value per share of employee stock purchase rights for the two-year offering period commencing on February 3, 2014 ranged from $2.82 to $4.48, compared to the estimated fair value per share from $2.93 to $4.57 for the two-year offering period commencing on February 1, 2013.

The fair value of each employee stock purchase right grant is estimated on the date of grant using the Black-Scholes option valuation model and is recognized as expense using the graded vesting method using the following assumptions:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

2014

 

September 30,

2013

 

September 30,

2014

 

 

September 30,

2013

 

Expected volatility

26.47-32.18%

 

42.40-48.89%

 

26.47-42.11%

 

 

42.40-50.55%

 

Risk-free interest rate

0.05-0.47%

 

0.08-0.35%

 

0.05-0.47%

 

 

0.08-0.35%

 

Expected dividends

0.0%

 

0.0%

 

 

0.0%

 

 

 

0.0%

 

Expected life (yrs)

0.5-2.0

 

0.5-2.0

 

0.5-2.0

 

 

0.5-2.0

 

 

The Company computed its expected volatility assumption based on blended volatility (50% historical volatility and 50% implied volatility). The selection of the blended volatility assumption was based upon the Company’s assessment that blended volatility is more representative of the Company’s future stock price trends as it weighs in the longer term historical volatility with the near term future implied volatility.

The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected life of the Company’s employee stock purchases.

The dividend yield assumption is based on the Company’s history of not paying dividends and future expectation of dividend payouts.

The expected life of employee stock purchase rights represents the contractual terms of the underlying program.

During the three months ended March 31, 2014, the Company performed its annual review of assumptions, which resulted in an increase in the forfeiture rate. The effect of the change in the forfeiture rate decreased stock-based compensation expense by approximately $1.8 million which decreased the Company’s net loss by approximately $1.4 million or $0.01 per share in the three months ended March 31, 2014. There was no material impact in the three months ended June 30, 2014 and September 30, 2014. Additionally, during the three months ended March 31, 2014, the Company recorded a benefit of $2.1 million related to actual forfeitures of awards granted to former officers, and there was no such benefit recorded in the three months ended June 30, 2014 and September 30, 2014.

Net Income Per Share
Net Income Per Share

16. NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share for the periods presented (in thousands, except for per-share amounts):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income from continuing operations

$

17,011

 

 

$

(23,978

)

 

 

21,577

 

 

 

(16,566

)

Gain from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

459

 

Net income

$

17,011

 

 

$

(23,978

)

 

$

21,577

 

 

$

(16,107

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

136,606

 

 

 

170,310

 

 

 

137,139

 

 

 

172,644

 

Effect of dilutive potential common shares

 

5,570

 

 

 

 

 

 

5,267

 

 

 

 

Weighted average shares outstanding, diluted

 

142,176

 

 

 

170,310

 

 

 

142,406

 

 

 

172,644

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share from continuing operations

$

0.12

 

 

$

(0.14

)

 

$

0.16

 

 

$

(0.10

)

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

$

0.12

 

 

$

(0.14

)

 

$

0.16

 

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share from continuing operations

$

0.12

 

 

$

(0.14

)

 

$

0.15

 

 

$

(0.10

)

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

$

0.12

 

 

$

(0.14

)

 

$

0.15

 

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Antidilutive employee stock-based awards, excluded

 

136

 

 

 

3,682

 

 

 

288

 

 

 

3,597

 

 

Diluted shares outstanding include the dilutive effect of in-the-money employee equity share options, unvested performance shares, restricted stock units, and stock purchase rights under ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period using the treasury stock method. Potentially dilutive shares are excluded from the computation of diluted net income per share when their effect is antidilutive.

Business Segment Information
Business Segment Information

17. BUSINESS SEGMENT INFORMATION

The Company conducts its business globally and is managed geographically in three segments: (1) Americas, which consist of North America and Caribbean and Latin America (“CALA”) reporting units, (2) Europe, Middle East and Africa (“EMEA”) and (3) Asia Pacific (“APAC”). The segments are determined in accordance with how management views and evaluates the Company’s business and allocates its resources, and based on the criteria as outlined in the authoritative guidance.

Segment Revenue and Profit

Segment revenues consist of product and service revenues. Product revenues are attributed to a segment based on the ordering location of the customer. For internal reporting purposes and determination of segment contribution margins, geographic segment product revenues may differ slightly from actual geographic revenues due to internal revenue allocations between the Company’s segments. Service revenues are generally attributed to a segment based on the end-user’s location where services are performed. A significant portion of each segment’s expenses arise from shared services and infrastructure that Polycom has historically allocated to the segments in order to realize economies of scale and to use resources efficiently.

Segment contribution margin includes all geographic segment revenues less the related cost of sales and direct sales and marketing expenses. Management allocates some infrastructure costs, such as facilities and IT costs, in determining segment contribution margins. Contribution margin is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. Certain operating expenses are not allocated to segments because they are separately managed at the corporate level. These unallocated costs include corporate manufacturing costs, sales and marketing costs other than direct sales and marketing expenses, research and development expenses, general and administrative costs, such as legal and accounting, stock-based compensation costs, transaction-related costs, amortization of purchased intangibles, restructuring costs and interest and other income (expense), net.

Segment Data

The results of the reportable segments are derived directly from Polycom’s management reporting system. The results are based on Polycom’s method of internal reporting and are not reported in conformity with accounting principles generally accepted in the United States. Management measures the performance of each segment based on several metrics, including contribution margin as defined above. Asset data, with the exception of gross accounts receivable, is not reviewed by management at the segment level.

Financial information for each reportable geographical segment as of September 30, 2014 and December 31, 2013 and for the three and nine months ended September 30, 2014 and 2013, based on the Company’s internal management reporting system and as utilized by the Company’s Chief Executive Officer who is its Chief Operating Decision Maker (“CODM”), is as follows (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

For the three months ended September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

166,354

 

 

$

83,995

 

 

$

85,337

 

 

$

335,686

 

% of total revenue

 

50

%

 

 

25

%

 

 

25

%

 

 

100

%

Contribution margin

 

66,993

 

 

 

36,686

 

 

 

35,965

 

 

 

139,644

 

% of segment revenue

 

40

%

 

 

44

%

 

 

42

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended September 30, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

177,285

 

 

$

80,015

 

 

$

79,161

 

 

$

336,461

 

% of total revenue

 

53

%

 

 

24

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,899

 

 

 

34,094

 

 

 

30,281

 

 

 

134,274

 

% of segment revenue

 

39

%

 

 

43

%

 

 

38

%

 

 

40

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

497,229

 

 

$

256,099

 

 

$

242,901

 

 

$

996,229

 

% of total revenue

 

50

%

 

 

26

%

 

 

24

%

 

 

100

%

Contribution margin

 

206,121

 

 

 

109,460

 

 

 

100,985

 

 

 

416,566

 

% of segment revenue

 

41

%

 

 

43

%

 

 

42

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

523,895

 

 

$

248,834

 

 

$

247,718

 

 

$

1,020,447

 

% of total revenue

 

52

%

 

 

24

%

 

 

24

%

 

 

100

%

Contribution margin

 

207,876

 

 

 

103,703

 

 

 

98,364

 

 

 

409,943

 

% of segment revenue

 

40

%

 

 

42

%

 

 

40

%

 

 

40

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2014: Gross accounts receivable

$

100,424

 

 

$

63,557

 

 

$

60,890

 

 

$

224,871

 

% of total gross accounts receivable

 

45

%

 

 

28

%

 

 

27

%

 

 

100

%

As of December 31, 2013: Gross accounts receivable

 

86,243

 

 

 

71,970

 

 

 

66,921

 

 

 

225,134

 

% of total gross accounts receivable

 

38

%

 

 

32

%

 

 

30

%

 

 

100

%

 

During the three months ended September 30, 2014, two customers from the Americas segment, ScanSource Communications (“ScanSource”) and Westcon Group Inc (“Westcon”), in aggregate, accounted for 26% of the Company’s revenues. In the nine months ended September 30, 2014, ScanSource accounted for 17% of the Company’s revenues. During the three and nine months ended 2013, ScanSource accounted for 17% of the Company’s revenues. At September 30, 2014 and December 31, 2013, ScanSource accounted for 19% and 11%, respectively, of total gross accounts receivable.

The reconciliation of segment information to Polycom consolidated totals is as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Segment contribution margin

$

139,644

 

 

$

134,274

 

 

$

416,566

 

 

$

409,943

 

Corporate and unallocated costs

 

(101,993

)

 

 

(110,640

)

 

 

(307,931

)

 

 

(323,645

)

Stock-based compensation

 

(14,768

)

 

 

(17,202

)

 

 

(34,178

)

 

 

(53,300

)

Effect of stock-based compensation cost on warranty expense

 

(204

)

 

 

(120

)

 

 

(410

)

 

 

(421

)

Amortization of purchased intangibles

 

(3,167

)

 

 

(3,735

)

 

 

(9,667

)

 

 

(11,279

)

Restructuring costs

 

2,631

 

 

 

(24,887

)

 

 

(36,887

)

 

 

(34,639

)

Litigation reserves and payments

 

(3,130

)

 

 

 

 

 

(3,130

)

 

 

 

Transaction-related costs

 

 

 

 

(39

)

 

 

(156

)

 

 

(3,411

)

Interest and other income (expense), net

 

(185

)

 

 

(1,634

)

 

 

(2,576

)

 

 

(2,777

)

Income from continuing operations before benefit from

     income taxes

$

18,828

 

 

$

(23,983

)

 

$

21,631

 

 

$

(19,529

)

 

The following table summarizes the Company’s revenues by groups of similar products and services as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UC group systems

$

217,256

 

 

$

221,370

 

 

$

649,076

 

 

$

686,795

 

UC personal devices

 

60,113

 

 

 

56,920

 

 

 

170,226

 

 

 

157,014

 

UC platform

 

58,317

 

 

 

58,171

 

 

 

176,927

 

 

 

176,638

 

Total

$

335,686

 

 

$

336,461

 

 

$

996,229

 

 

$

1,020,447

 

 

 

Income Taxes
Income Taxes

18. INCOME TAXES

The following table presents the income tax expense (benefit) from continuing operations and the effective tax rates (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Income tax expense (benefit) from continuing operations

$

1,817

 

 

$

(5

)

 

$

54

 

 

$

(2,963

)

Effective tax rate

 

9.7

%

 

 

0.02

%

 

 

0.2

%

 

 

15.2

%

 

The effective tax rate for the three and nine months ended September 30, 2014 and 2013 differ from the U.S. federal statutory rate of 35% primarily due to impacts associated with proportional earnings from the Company’s operations in lower tax jurisdictions, recurring permanent adjustments, and discrete benefits recorded during the quarters. For the three and nine months ended September 30, 2014, discrete benefits of $0.7 million and $2.2 million were recorded for tax benefits realized on disqualifying dispositions of stock from the Company’s employee stock purchase plan. In addition, included in the tax rate for the nine months ended September 30, 2014 is a discrete tax benefit recorded in the first quarter of $0.9 million related to stock-based compensation expense adjustments for certain terminated employees and a $0.8 million benefit related to the expiration of certain statutes recorded in the third quarter of 2014. Discrete benefits recorded during the three and nine months ended September 30, 2013 include $2.2 million recorded in the first quarter of 2013 related to the reinstatement of the federal research and development tax credit signed into law on January 2, 2013, but retroactive to 2012,  $1.0 million of which was recorded in the second quarter of 2013 related to previously non-deductible acquisition-related expenses that became deductible in the quarter, and a $2.0 million reserve release inclusive of interest which was recorded in the third quarter due to the expiration of a statute of limitations. In addition, $1.5 million of tax benefits realized on disqualifying dispositions of stock from the Company’s employee stock purchase plan were recorded in the nine months ended September 30, 2013, $0.5 million of which was recorded in the third quarter of 2013.

As of September 30, 2014, the amount of gross unrecognized tax benefits was $21.3 million, all of which would affect the Company’s effective tax rate if realized. The Company recognizes interest income and interest expense and penalties on tax overpayments and underpayments within income tax expense. As of September 30, 2014 and December 31, 2013, the Company had approximately $1.6 million and $1.5 million, respectively, of accrued interest and penalties related to uncertain tax positions. The Company anticipates that, except for $0.6 million in uncertain tax positions that may be reduced related to the lapse of various statutes of limitation, there will be no material changes in uncertain tax positions in the next 12 months.

The Company regularly assesses the ability to realize deferred tax assets recorded in all entities based upon the weight of available evidence, including such factors as recent earnings history and expected future taxable income. If the Company’s future business profits do not support the realization of deferred tax assets, a valuation allowance could be recorded in the foreseeable future. In the event that the Company changes its determination as to the amount of deferred tax assets that can be realized, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.

Basis of Presentation (Tables)
Revision to the Condensed Consolidated Statement of Cash Flows

The following table sets forth a summary of the revision to the condensed consolidated statement of cash flows for the following period (in thousands):

 

 

Nine Months Ended September 30, 2013

 

 

As Previously

Reported

 

 

Adjustment

 

 

As Revised

 

Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

 

Amortization of discounts and premiums on investments, net

$

 

 

$

1,323

 

 

$

1,323

 

Net cash provided by operating activities

$

117,469

 

 

$

1,323

 

 

$

118,792

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

$

(200,945

)

 

$

(1,323

)

 

$

(202,268

)

Net cash used in investing activities

$

(42,720

)

 

$

(1,323

)

 

$

(44,043

)

 

Goodwill, Purchased Intangibles, and Software Development Costs (Tables)

The following table presents the changes to the Company’s goodwill by segment during the nine months ended September 30, 2014 (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

Balance at December 31, 2013

$

308,159

 

 

$

101,882

 

 

$

149,419

 

 

$

559,460

 

Foreign currency translation

 

 

 

 

 

 

 

(173

)

 

 

(173

)

Balance at September, 30, 2014

$

308,159

 

 

$

101,882

 

 

$

149,246

 

 

$

559,287

 

 

 

The following table presents details of the Company’s total purchased intangible assets and capitalized software development costs for products to be sold as of the following periods (in thousands):

 

 

September 30, 2014

 

 

December 31, 2013

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

 

Gross

Value

 

 

Accumulated

Amortization

& Impairment

 

 

Net Value

 

Core and developed technology

$

81,178

 

 

$

(79,256

)

 

$

1,922

 

 

$

81,178

 

 

$

(76,952

)

 

$

4,226

 

Customer and partner relationships

 

79,525

 

 

 

(55,749

)

 

 

23,776

 

 

 

79,525

 

 

 

(48,941

)

 

 

30,584

 

Non-compete agreements

 

1,800

 

 

 

(950

)

 

 

850

 

 

 

1,800

 

 

 

(500

)

 

 

1,300

 

Trade name

 

3,400

 

 

 

(3,194

)

 

 

206

 

 

 

3,400

 

 

 

(3,089

)

 

 

311

 

Other

 

4,462

 

 

 

(4,400

)

 

 

62

 

 

 

4,462

 

 

 

(4,343

)

 

 

119

 

Finite-lived intangible assets

 

170,365

 

 

 

(143,549

)

 

 

26,816

 

 

 

170,365

 

 

 

(133,825

)

 

 

36,540

 

Indefinite-lived trade name

 

918

 

 

 

 

 

 

918

 

 

 

918

 

 

 

 

 

 

918

 

Total acquired intangible assets

$

171,283

 

 

$

(143,549

)

 

$

27,734

 

 

$

171,283

 

 

$

(133,825

)

 

$

37,458

 

Capitalized software development costs for products to be sold

$

5,575

 

 

$

(1,465

)

 

$

4,110

 

 

$

2,365

 

 

$

(196

)

 

$

2,169

 

 

The following table summarizes the amortization expenses recorded in the following periods (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Amortization of purchased intangibles in revenues

$

19

 

 

$

19

 

 

$

57

 

 

$

56

 

Amortization of purchased intangibles in cost of product revenues

 

732

 

 

 

1,248

 

 

 

2,304

 

 

 

3,744

 

Amortization of purchased intangibles in operating expenses

 

2,435

 

 

 

2,487

 

 

 

7,363

 

 

 

7,535

 

Total amortization expenses of purchased intangibles

$

3,186

 

 

$

3,754

 

 

$

9,724

 

 

$

11,335

 

 

The estimated future amortization expense as of September 30, 2014 is as follows (in thousands):

 

Year ending December 31,

 

Amount

 

Remainder of 2014

 

$

3,167

 

2015

 

 

10,495

 

2016

 

 

8,484

 

2017

 

 

4,670

 

2018

 

 

 

Total

 

$

26,816

 

 

Restructuring Costs (Tables)
Summary of Activity of Restructuring Reserves

The following table summarizes the changes in the Company’s restructuring reserves during the nine months ended September 30, 2014 (in thousands):

 

 

Severance/Other

 

 

Facilities

 

 

Total

 

Balance at December 31, 2013

$

1,143

 

 

$

33,786

 

 

$

34,929

 

Additions to the reserve, net

 

11,106

 

 

 

23,991

 

 

 

35,097

 

Interest accretion

 

 

 

 

1,790

 

 

 

1,790

 

Non-cash write-offs

 

 

 

 

(2,576

)

 

 

(2,576

)

Cash payments and other usage

 

(10,790

)

 

 

(15,624

)

 

 

(26,414

)

Balance at September 30, 2014

$

1,459

 

 

$

41,367

 

 

$

42,826

 

 

Balance Sheet Details (Tables)

Trade receivables, net consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Gross accounts receivables

$

224,871

 

 

$

225,134

 

Returns and related reserves

 

(40,319

)

 

 

(38,938

)

Allowance for doubtful accounts

 

(3,105

)

 

 

(2,827

)

Total

$

181,447

 

 

$

183,369

 

 

Inventories consist of the following (in thousands):

 

September 30,

2014

 

 

December 31,

2013

 

Raw materials

$

2,657

 

 

$

2,740

 

Work in process

 

1,018

 

 

 

840

 

Finished goods

 

94,274

 

 

 

99,729

 

Total

$

97,949

 

 

$

103,309

 

 

 

 

Prepaid expenses and other current assets consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Non-trade receivables

$

5,056

 

 

$

9,251

 

Prepaid expenses

 

42,548

 

 

 

31,164

 

Derivative assets

 

10,454

 

 

 

6,748

 

Other current assets

 

5,156

 

 

 

3,189

 

Total

$

63,214

 

 

$

50,352

 

 

Deferred revenue consists of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Short-term:

 

 

 

 

 

 

 

Service

$

173,367

 

 

$

170,701

 

Product

 

112

 

 

 

307

 

License

 

1,828

 

 

 

1,400

 

Total

$

175,307

 

 

$

172,408

 

Long-term:

 

 

 

 

 

 

 

Service

$

78,495

 

 

$

83,092

 

Product

 

 

 

 

 

License

 

3,606

 

 

 

4,375

 

Total

$

82,101

 

 

$

87,467

 

 

Changes in the deferred service revenue are as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Balance at beginning of period

$

252,995

 

 

$

252,091

 

 

$

253,793

 

 

$

241,773

 

Additions to deferred service revenue

 

85,246

 

 

 

87,993

 

 

 

255,705

 

 

 

268,392

 

Amortization of deferred service revenue

 

(86,379

)

 

 

(86,114

)

 

 

(257,636

)

 

 

(256,195

)

Balance at end of period

$

251,862

 

 

$

253,970

 

 

$

251,862

 

 

$

253,970

 

 

Other accrued liabilities consist of the following (in thousands):

 

 

September 30,

2014

 

 

December 31,

2013

 

Accrued expenses

$

27,222

 

 

$

22,515

 

Accrued co-op expenses

 

4,068

 

 

 

4,629

 

Restructuring reserves

 

15,344

 

 

 

11,238

 

Warranty obligations

 

10,766

 

 

 

9,475

 

Derivative liabilities

 

5,262

 

 

 

6,780

 

Employee stock purchase plan withholdings

 

5,129

 

 

 

10,883

 

Other accrued liabilities

 

10,688

 

 

 

12,224

 

Total

$

78,479

 

 

$

77,744

 

 

Changes in the warranty obligation are as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Balance at beginning of period

$

10,350

 

 

$

9,686

 

 

$

9,475

 

 

$

10,475

 

Accruals for warranties issued during the period

 

3,846

 

 

 

4,295

 

 

 

11,977

 

 

 

12,407

 

Actual charges against warranty reserve during the period

 

(3,430

)

 

 

(4,270

)

 

 

(10,686

)

 

 

(13,171

)

Balance at end of period

$

10,766

 

 

$

9,711

 

 

$

10,766

 

 

$

9,711

 

 

Debt (Tables)
Interest Expense Recognized Related to Term Loan

The following table sets forth total interest expense recognized on the Term Loan (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Contractual interest expense

$

1,233

 

 

$

305

 

 

$

3,687

 

 

$

305

 

Amortization of debt issuance costs

 

133

 

 

 

52

 

 

 

400

 

 

 

52

 

Total

$

1,366

 

 

$

357

 

 

$

4,087

 

 

$

357

 

 

Investments (Tables)

In addition, the Company has short-term and long-term investments in debt securities which are summarized as follows (in thousands):

 

 

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair Value

 

Balances at September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

28,888

 

 

$

23

 

 

$

 

 

$

28,911

 

U.S. government agency securities

 

39,246

 

 

 

19

 

 

 

(1

)

 

 

39,264

 

Non-U.S. government securities

 

6,804

 

 

 

4

 

 

 

 

 

 

6,808

 

Corporate debt securities

 

76,088

 

 

 

21

 

 

 

(23

)

 

 

76,086

 

Total investments - short-term

$

151,026

 

 

$

67

 

 

$

(24

)

 

$

151,069

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

28,544

 

 

$

14

 

 

$

(2

)

 

$

28,556

 

U.S. government agency securities

 

30,664

 

 

 

5

 

 

 

(28

)

 

 

30,641

 

Non-U.S. government securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

26,422

 

 

 

4

 

 

 

(24

)

 

 

26,402

 

Total investments - long-term

$

85,630

 

 

$

23

 

 

$

(54

)

 

$

85,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments-Short-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

19,792

 

 

$

9

 

 

$

 

 

$

19,801

 

U.S. government agency securities

 

38,388

 

 

 

16

 

 

 

(3

)

 

 

38,401

 

Non-U.S. government securities

 

13,734

 

 

 

10

 

 

 

 

 

 

13,744

 

Corporate debt securities

 

62,720

 

 

 

22

 

 

 

(4

)

 

 

62,738

 

Total investments - short-term

$

134,634

 

 

$

57

 

 

$

(7

)

 

$

134,684

 

Investments-Long-term:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

12,252

 

 

$

8

 

 

$

 

 

$

12,260

 

U.S. government agency securities

 

30,627

 

 

 

12

 

 

 

(3

)

 

 

30,636

 

Non-U.S. government securities

 

2,305

 

 

 

4

 

 

 

 

 

 

2,309

 

Corporate debt securities

 

11,152

 

 

 

15

 

 

 

 

 

 

11,167

 

Total investments - long-term

$

56,336

 

 

$

39

 

 

$

(3

)

 

$

56,372

 

 

The following table summarizes the fair value and gross unrealized losses of the Company’s investments, including those that are categorized as cash equivalents, with unrealized losses aggregated by type of investment instrument and length of time that individual securities have been in a continuous unrealized loss position as of September 30, 2014 and December 31, 2013 (in thousands):

 

 

Less than 12 Months

 

 

12 Months or Greater

 

 

Total

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

 

Gross

Unrealized

Losses

 

September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government securities

$

5,478

 

 

$

(2

)

 

$

 

 

$

 

 

$

5,478

 

 

$

(2

)

U.S. government agency securities

 

19,964

 

 

 

(29

)

 

 

 

 

 

 

 

 

19,964

 

 

 

(29

)

Corporate debt securities

 

54,662

 

 

 

(47

)

 

 

 

 

 

 

 

 

54,662

 

 

 

(47

)

Total investments

$

80,104

 

 

$

(78

)

 

$

 

 

$

 

 

$

80,104

 

 

$

(78

)

December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government agency securities

$

5,533

 

 

$

(6

)

 

$

 

 

$

 

 

$

5,533

 

 

$

(6

)

Corporate debt securities

 

9,837

 

 

 

(3

)

 

 

1,504

 

 

 

(1

)

 

 

11,341

 

 

 

(4

)

Total investments

$

15,370

 

 

$

(9

)

 

$

1,504

 

 

$

(1

)

 

$

16,874

 

 

$

(10

)

 

Fair Value Measurements (Tables)
Schedule of Fair Value of Marketable Securities and Foreign Currency Contracts

The fair value of the Company’s marketable securities and foreign currency contracts was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements at

September 30, 2014 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

251,969

 

 

$

6,052

 

 

$

245,917

 

Foreign currency forward contracts (b)

 

$

10,454

 

 

$

 

 

$

10,454

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

5,262

 

 

$

 

 

$

5,262

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at

December 31, 2013 Using

 

Description

 

Total

 

 

Quoted Prices in Active

Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income available-for-sale securities (a)

 

$

211,151

 

 

$

17,596

 

 

$

193,555

 

Foreign currency forward contracts (b)

 

$

6,748

 

 

$

 

 

$

6,748

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts (c)

 

$

6,780

 

 

$

 

 

$

6,780

 

 

(a)

Included in cash and cash equivalents, and short and long-term investments in the Company’s condensed consolidated balance sheets.

(b)

Included in short-term derivative assets as prepaid expenses and other current assets in the Company’s condensed consolidated balance sheets.

(c)

Included in short-term derivative liabilities as other accrued liabilities in the Company’s condensed consolidated balance sheets.

Foreign Currency Derivatives (Tables)

The following table shows the Company’s derivative instruments measured at gross fair value as reflected in the condensed consolidated balance sheets as of the periods presented (in thousands):

 

 

Fair Value of

Derivatives Designated

as Hedge Instruments

 

 

Fair Value of Derivatives

Not Designated as Hedge

Instruments

 

 

September 30,

2014

 

 

December 31,

2013

 

 

September 30,

2014

 

 

December 31,

2013

 

Derivative assets (a):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

5,122

 

 

$

4,457

 

 

$

5,332

 

 

$

2,291

 

Derivative liabilities (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

$

3,281

 

 

$

4,235

 

 

$

1,981

 

 

$

2,545

 

 

  

 

(a)

All derivative assets are recorded in “Prepaid and other current assets” in the condensed consolidated balance sheets.

(b)

All derivative liabilities are recorded in “Other accrued liabilities” in the condensed consolidated balance sheets.

The following table sets forth the offsetting of derivative assets (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

Gross Amounts of Recognized Assets

 

 

Gross Amounts

Offset in the Condensed Consolidated

Balance Sheets

 

 

Net Amounts Of Assets Presented In the Condensed Consolidated Balance Sheets

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

10,454

 

 

$

 

 

$

10,454

 

 

$

(5,259

)

 

$

 

 

$

5,195

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,748

 

 

$

 

 

$

6,748

 

 

$

(5,643

)

 

$

 

 

$

1,105

 

 

 

 

The following table sets forth the offsetting of derivative liabilities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Amounts Not Offset in the

Condensed Consolidated Balance Sheets

 

 

 

Gross Amounts of Recognized Liabilities

 

 

Gross Amounts

Offset in the Condensed Consolidated

Balance Sheets

 

 

Net Amounts Of Liabilities Presented In the Condensed Consolidated Balance Sheets

 

 

Financial

Instruments

 

 

Cash

Collateral

Pledged

 

 

Net

Amount

 

As of September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

5,262

 

 

$

 

 

$

5,262

 

 

$

(5,259

)

 

$

 

 

$

3

 

As of December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

$

6,780

 

 

$

 

 

$

6,780

 

 

$

(5,643

)

 

$

 

 

$

1,137

 

 

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent of the outstanding cash flow hedges at September 30, 2014 (in thousands):

 

 

 

Original Maturities

of 360 Days or Less

 

Original Maturities

of Greater than 360 Days

 

 

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Chinese Yuan

 

 

119,271

 

 

$

18,931

 

 

Buy

 

 

 

 

$

 

 

 

Euro

 

 

25,966

 

 

$

34,655

 

 

Buy

 

 

 

 

 

 

 

 

 

Euro

 

 

62,368

 

 

$

83,220

 

 

Sell

 

 

 

 

 

 

 

 

 

British Pound

 

 

21,054

 

 

$

34,737

 

 

Buy

 

 

 

 

 

 

 

 

 

British Pound

 

 

25,028

 

 

$

41,308

 

 

Sell

 

 

 

 

 

 

 

 

 

Israeli Shekel

 

 

82,564

 

 

$

23,359

 

 

Buy

 

 

 

 

 

 

 

 

 

 

The following tables show the effect of the Company’s derivative instruments designated as cash flow hedges in the condensed consolidated statements of operations for the following periods (in thousands):

 

 

 

Gain or (Loss) Recognized in OCI-Effective Portion

 

 

Location of Gain or (Loss) Reclassified from OCI into Income-Effective Portion

 

Gain or (Loss) Reclassified from OCI into Income-Effective Portion

 

 

Location of Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from

Effectiveness Testing

 

Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness

Testing (a)

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

 

Three Months Ended

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

$

2,573

 

 

$

(570

)

 

Product revenues

 

$

1,222

 

 

$

716

 

 

Interest and other income (expense), net

 

$

49

 

 

$

113

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

17

 

 

 

90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

(60

)

 

 

34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and

   development

 

 

3

 

 

 

423

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and

   administrative

 

 

160

 

 

 

(33

)

 

 

 

 

 

 

 

 

 

 

 

 

$

2,573

 

 

$

(570

)

 

 

 

$

1,342

 

 

$

1,230

 

 

 

 

$

49

 

 

$

113

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

 

 

Nine Months Ended

 

 

 

 

Nine Months Ended

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

$

2,574

 

 

$

1,793

 

 

Product revenues

 

$

(3,052

)

 

$

1,190

 

 

Interest and other income (expense), net

 

$

(3

)

 

$

273

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

879

 

 

 

138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

1,737

 

 

 

(73

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and

   development

 

 

695

 

 

 

1,075

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and

   administrative

 

 

526

 

 

 

26

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2,574

 

 

$

1,793

 

 

 

 

$

785

 

 

$

2,356

 

 

 

 

$

(3

)

 

$

273

 

 

  

 

(a)There were no gains or losses recognized in income due to ineffectiveness in the periods presented.

The following table summarizes the Company’s notional position by currency, and approximate U.S. dollar equivalent of the outstanding non-designated hedges at September 30, 2014 (in thousands):

 

 

Original Maturities of 360 Days or Less

 

Original Maturities of Greater than 360 Days

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

 

Foreign

Currency

 

 

USD

Equivalent

 

 

Positions

Brazilian Real

 

10,508

 

 

$

4,287

 

 

Buy

 

 

 

 

$

 

 

Brazilian Real

 

19,975

 

 

$

8,487

 

 

Sell

 

 

 

 

 

 

 

Chinese Yuan

 

132,129

 

 

$

21,457

 

 

Buy

 

 

 

 

$

 

 

Chinese Yuan

 

128,938

 

 

$

20,724

 

 

Sell

 

 

 

 

$

 

 

Euro

 

21,287

 

 

$

27,031

 

 

Buy

 

 

6,400

 

 

$

8,629

 

 

Buy

Euro

 

50,325

 

 

$

65,702

 

 

Sell

 

 

20,800

 

 

$

28,043

 

 

Sell

British Pound

 

22,223

 

 

$

36,504

 

 

Buy

 

 

6,600

 

 

$

10,551

 

 

Buy

British Pound

 

19,126

 

 

$

31,426

 

 

Sell

 

 

7,800

 

 

$

12,469

 

 

Sell

Israeli Shekel

 

18,043

 

 

$

4,923

 

 

Buy

 

 

30,900

 

 

$

8,706

 

 

Buy

Israeli Shekel

 

41,125

 

 

$

11,305

 

 

Sell

 

 

 

 

$

 

 

Japanese Yen

 

514,868

 

 

$

4,694

 

 

Buy

 

 

 

 

$

 

 

Japanese Yen

 

930,002

 

 

$

8,745

 

 

Sell

 

 

 

 

$

 

 

Mexican Peso

 

14,129

 

 

$

1,052

 

 

Buy

 

 

 

 

$

 

 

Mexican Peso

 

24,673

 

 

$

1,861

 

 

Sell

 

 

 

 

$

 

 

 

The following table shows the effect of the Company’s non-designated hedges in the condensed consolidated statements of operations for the following periods (in thousands):

 

Derivatives Not Designated as

Hedging Instruments

 

Location of Gain or (Loss)

Recognized in Income on Derivative

 

Amount of Gain or (Loss)

Recognized in Income on Derivative

 

 

 

 

 

Three Months Ended

 

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

3,991

 

 

$

(1,783

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended

 

 

 

 

 

September 30,

2014

 

 

September 30,

2013

 

Foreign exchange contracts

 

Interest and other income (expense), net

 

$

4,290

 

 

$

(182

)

 

 

Stockholders' Equity (Tables)
Changes in Accumulated Other Comprehensive Income (Loss) by Component

The following table summarizes the changes in accumulated other comprehensive income, net of tax, by component for the nine months ended September 30, 2014 (in thousands). The tax effects were not shown separately, as the impacts were not material.

 

Nine Months Ended September 30, 2014

 

Unrealized

Gains and

Losses on

Cash Flow

Hedges

 

 

Unrealized Gains

and Losses on

Available-for-

Sale Securities

 

 

Foreign Currency

Translation

 

 

Total

 

Balance as of December 31, 2013

 

$

80

 

 

$

73

 

 

$

4,219

 

 

$

4,372

 

Other comprehensive income (loss) before reclassifications

 

 

2,574

 

 

 

(43

)

 

 

(907

)

 

 

1,624

 

Amounts reclassified from accumulated

     other comprehensive income (a)

 

 

(785

)

 

 

(9

)

 

 

 

 

 

(794

)

Net current-period other comprehensive income (loss)

 

 

1,789

 

 

 

(52

)

 

 

(907

)

 

 

830

 

Balance as of September 30, 2014

 

$

1,869

 

 

$

21

 

 

$

3,312

 

 

$

5,202

 

 

 

 

(a)

See Note 13 of Notes to Condensed Consolidated Financial Statements for details of gains and losses, net of taxes, reclassified out of accumulated other comprehensive income into net income related to cash flow hedges and each line item of net income affected by the reclassification. Gains and losses related to available-for-sale securities were reclassified into “Other income (expense)” in the condensed consolidated statement of operations for the nine months ended September 30, 2014, net of taxes.

Stock-Based Compensation (Tables)

The following table summarizes stock-based compensation expense recorded for the periods presented and its allocation within the condensed consolidated statements of operations (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Cost of sales - product

$

668

 

 

$

686

 

 

$

1,828

 

 

$

2,252

 

Cost of sales - service

 

1,102

 

 

 

1,479

 

 

 

3,164

 

 

 

4,600

 

Stock-based compensation expense included in cost of sales

 

1,770

 

 

 

2,165

 

 

 

4,992

 

 

 

6,852

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

4,673

 

 

 

5,889

 

 

 

10,397

 

 

 

19,742

 

Research and development

 

3,203

 

 

 

3,669

 

 

 

7,304

 

 

 

12,578

 

General and administrative

 

5,122

 

 

 

5,479

 

 

 

11,485

 

 

 

14,128

 

Stock-based compensation expense included in operating

     expenses

 

12,998

 

 

 

15,037

 

 

 

29,186

 

 

 

46,448

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases

 

14,768

 

 

 

17,202

 

 

 

34,178

 

 

 

53,300

 

Tax benefit

 

3,016

 

 

 

7,960

 

 

 

6,778

 

 

 

24,663

 

Stock-based compensation expense related to employee

     equity awards and employee stock purchases, net of tax

$

11,752

 

 

$

9,242

 

 

$

27,400

 

 

$

28,637

 

 

The fair value of each employee stock purchase right grant is estimated on the date of grant using the Black-Scholes option valuation model and is recognized as expense using the graded vesting method using the following assumptions:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

2014

 

September 30,

2013

 

September 30,

2014

 

 

September 30,

2013

 

Expected volatility

26.47-32.18%

 

42.40-48.89%

 

26.47-42.11%

 

 

42.40-50.55%

 

Risk-free interest rate

0.05-0.47%

 

0.08-0.35%

 

0.05-0.47%

 

 

0.08-0.35%

 

Expected dividends

0.0%

 

0.0%

 

 

0.0%

 

 

 

0.0%

 

Expected life (yrs)

0.5-2.0

 

0.5-2.0

 

0.5-2.0

 

 

0.5-2.0

 

 

Net Income Per Share (Tables)
Reconciliation of Numerator and Denominator of Basic and Diluted Net Income Per Share

The following table sets forth the computation of basic and diluted net income per share for the periods presented (in thousands, except for per-share amounts):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income from continuing operations

$

17,011

 

 

$

(23,978

)

 

 

21,577

 

 

 

(16,566

)

Gain from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

459

 

Net income

$

17,011

 

 

$

(23,978

)

 

$

21,577

 

 

$

(16,107

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

 

136,606

 

 

 

170,310

 

 

 

137,139

 

 

 

172,644

 

Effect of dilutive potential common shares

 

5,570

 

 

 

 

 

 

5,267

 

 

 

 

Weighted average shares outstanding, diluted

 

142,176

 

 

 

170,310

 

 

 

142,406

 

 

 

172,644

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share from continuing operations

$

0.12

 

 

$

(0.14

)

 

$

0.16

 

 

$

(0.10

)

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

$

0.12

 

 

$

(0.14

)

 

$

0.16

 

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share from continuing operations

$

0.12

 

 

$

(0.14

)

 

$

0.15

 

 

$

(0.10

)

Gain per share from sale of discontinued operations, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

$

0.12

 

 

$

(0.14

)

 

$

0.15

 

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Antidilutive employee stock-based awards, excluded

 

136

 

 

 

3,682

 

 

 

288

 

 

 

3,597

 

 

Business Segment Information (Tables)

Financial information for each reportable geographical segment as of September 30, 2014 and December 31, 2013 and for the three and nine months ended September 30, 2014 and 2013, based on the Company’s internal management reporting system and as utilized by the Company’s Chief Executive Officer who is its Chief Operating Decision Maker (“CODM”), is as follows (in thousands):

 

 

Americas

 

 

EMEA

 

 

APAC

 

 

Total

 

For the three months ended September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

166,354

 

 

$

83,995

 

 

$

85,337

 

 

$

335,686

 

% of total revenue

 

50

%

 

 

25

%

 

 

25

%

 

 

100

%

Contribution margin

 

66,993

 

 

 

36,686

 

 

 

35,965

 

 

 

139,644

 

% of segment revenue

 

40

%

 

 

44

%

 

 

42

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended September 30, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

177,285

 

 

$

80,015

 

 

$

79,161

 

 

$

336,461

 

% of total revenue

 

53

%

 

 

24

%

 

 

23

%

 

 

100

%

Contribution margin

 

69,899

 

 

 

34,094

 

 

 

30,281

 

 

 

134,274

 

% of segment revenue

 

39

%

 

 

43

%

 

 

38

%

 

 

40

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

497,229

 

 

$

256,099

 

 

$

242,901

 

 

$

996,229

 

% of total revenue

 

50

%

 

 

26

%

 

 

24

%

 

 

100

%

Contribution margin

 

206,121

 

 

 

109,460

 

 

 

100,985

 

 

 

416,566

 

% of segment revenue

 

41

%

 

 

43

%

 

 

42

%

 

 

42

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

523,895

 

 

$

248,834

 

 

$

247,718

 

 

$

1,020,447

 

% of total revenue

 

52

%

 

 

24

%

 

 

24

%

 

 

100

%

Contribution margin

 

207,876

 

 

 

103,703

 

 

 

98,364

 

 

 

409,943

 

% of segment revenue

 

40

%

 

 

42

%

 

 

40

%

 

 

40

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2014: Gross accounts receivable

$

100,424

 

 

$

63,557

 

 

$

60,890

 

 

$

224,871

 

% of total gross accounts receivable

 

45

%

 

 

28

%

 

 

27

%

 

 

100

%

As of December 31, 2013: Gross accounts receivable

 

86,243

 

 

 

71,970

 

 

 

66,921

 

 

 

225,134

 

% of total gross accounts receivable

 

38

%

 

 

32

%

 

 

30

%

 

 

100

%

 

The reconciliation of segment information to Polycom consolidated totals is as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Segment contribution margin

$

139,644

 

 

$

134,274

 

 

$

416,566

 

 

$

409,943

 

Corporate and unallocated costs

 

(101,993

)

 

 

(110,640

)

 

 

(307,931

)

 

 

(323,645

)

Stock-based compensation

 

(14,768

)

 

 

(17,202

)

 

 

(34,178

)

 

 

(53,300

)

Effect of stock-based compensation cost on warranty expense

 

(204

)

 

 

(120

)

 

 

(410

)

 

 

(421

)

Amortization of purchased intangibles

 

(3,167

)

 

 

(3,735

)

 

 

(9,667

)

 

 

(11,279

)

Restructuring costs

 

2,631

 

 

 

(24,887

)

 

 

(36,887

)

 

 

(34,639

)

Litigation reserves and payments

 

(3,130

)

 

 

 

 

 

(3,130

)

 

 

 

Transaction-related costs

 

 

 

 

(39

)

 

 

(156

)

 

 

(3,411

)

Interest and other income (expense), net

 

(185

)

 

 

(1,634

)

 

 

(2,576

)

 

 

(2,777

)

Income from continuing operations before benefit from

     income taxes

$

18,828

 

 

$

(23,983

)

 

$

21,631

 

 

$

(19,529

)

 

The following table summarizes the Company’s revenues by groups of similar products and services as follows (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UC group systems

$

217,256

 

 

$

221,370

 

 

$

649,076

 

 

$

686,795

 

UC personal devices

 

60,113

 

 

 

56,920

 

 

 

170,226

 

 

 

157,014

 

UC platform

 

58,317

 

 

 

58,171

 

 

 

176,927

 

 

 

176,638

 

Total

$

335,686

 

 

$

336,461

 

 

$

996,229

 

 

$

1,020,447

 

 

 

Income Taxes (Tables)
Income Tax Expense (Benefit) from Continuing Operations and Effective Tax Rates

The following table presents the income tax expense (benefit) from continuing operations and the effective tax rates (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

2014

 

 

September 30,

2013

 

 

September 30,

2014

 

 

September 30,

2013

 

Income tax expense (benefit) from continuing operations

$

1,817

 

 

$

(5

)

 

$

54

 

 

$

(2,963

)

Effective tax rate

 

9.7

%

 

 

0.02

%

 

 

0.2

%

 

 

15.2

%

 

Basis of Presentation - Revision to the Condensed Consolidated Statement of Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Change In Accounting Estimate [Line Items]
 
 
Amortization of discounts and premiums on investments, net
$ 1,440 
$ 1,323 
Net cash provided by operating activities
114,649 
118,792 
Purchases of investments
(220,575)
(202,268)
Net cash used in investing activities
(87,029)
(44,043)
As Previously Reported
 
 
Change In Accounting Estimate [Line Items]
 
 
Net cash provided by operating activities
 
117,469 
Purchases of investments
 
(200,945)
Net cash used in investing activities
 
(42,720)
Adjustment
 
 
Change In Accounting Estimate [Line Items]
 
 
Amortization of discounts and premiums on investments, net
 
1,323 
Net cash provided by operating activities
 
1,323 
Purchases of investments
 
(1,323)
Net cash used in investing activities
 
$ (1,323)
Discontinued Operations - Additional Information (Details) (USD $)
0 Months Ended 9 Months Ended
Dec. 4, 2012
Sep. 30, 2014
Sep. 30, 2013
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
 
Gain from sale of discontinued operations, net of taxes
$ 35,400,000 
$ 0 
$ 459,000 
Mobile Devices Holdings LLC
 
 
 
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
 
Cash proceeds received
50,700,000 
 
 
Mobile Devices Holdings LLC |
Maximum
 
 
 
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
 
 
 
Additional cash consideration payable over the next three years subject to certain conditions, including meeting certain agreed-upon EBITDA-based milestones
 
$ 37,500,000 
 
Business Combinations - Additional Information (Details) (USD $)
1 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Business Combinations [Abstract]
 
 
Net cash paid in acquisitions
 
$ 7,974,000 
Cash received from net working capital adjustment
$ 400,000 
 
Accounts Receivable Financing - Additional Information (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Accounts Notes And Loans Receivable [Line Items]
 
 
 
 
 
Amount of total outstanding accounts receivable under a financing arrangement
$ 48.8 
$ 32.6 
$ 132.6 
$ 83.3 
 
Amount due from the financing company
23.7 
 
23.7 
 
22.9 
Fees incurred pursuant to the factoring agreement
0.7 
0.5 
1.8 
1.2 
 
Transfer Of Financial Assets Under Financing Arrangement
 
 
 
 
 
Accounts Notes And Loans Receivable [Line Items]
 
 
 
 
 
Amount of total outstanding accounts receivable under a financing arrangement
29.4 
27.9 
98.1 
73.1 
 
Amount due from the financing company
$ 16.5 
 
$ 16.5 
 
$ 21.6 
Goodwill, Purchased Intangibles, and Software Development Costs - Schedule of Goodwill by Segment (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Goodwill [Line Items]
 
Beginning Balance
$ 559,460 
Foreign currency translation
(173)
Ending Balance
559,287 
Americas
 
Goodwill [Line Items]
 
Beginning Balance
308,159 
Foreign currency translation
Ending Balance
308,159 
EMEA
 
Goodwill [Line Items]
 
Beginning Balance
101,882 
Foreign currency translation
Ending Balance
101,882 
APAC
 
Goodwill [Line Items]
 
Beginning Balance
149,419 
Foreign currency translation
(173)
Ending Balance
$ 149,246 
Goodwill, Purchased Intangibles, and Software Development Costs - Schedule of Purchased Intangible Assets by Major Class (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
$ 170,365 
$ 170,365 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(143,549)
(133,825)
Finite Lived Intangible Assets, Net Value
26,816 
36,540 
Indefinite-lived trade name
918 
918 
Total intangible assets, Gross Value
171,283 
171,283 
Total intangible assets, Accumulated Amortization and Impairment
(143,549)
(133,825)
Total intangible assets, Net Value
27,734 
37,458 
Capitalized software development costs for products to be sold, Gross Value
5,575 
2,365 
Capitalized software development costs for products to be sold, Accumulated Amortization & Impairment
(1,465)
(196)
Capitalized software development costs for products to be sold, Net Value
4,110 
2,169 
Core and developed technology
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
81,178 
81,178 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(79,256)
(76,952)
Finite Lived Intangible Assets, Net Value
1,922 
4,226 
Customer and partner relationships
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
79,525 
79,525 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(55,749)
(48,941)
Finite Lived Intangible Assets, Net Value
23,776 
30,584 
Non-compete agreement
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
1,800 
1,800 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(950)
(500)
Finite Lived Intangible Assets, Net Value
850 
1,300 
Trade name
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
3,400 
3,400 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(3,194)
(3,089)
Finite Lived Intangible Assets, Net Value
206 
311 
Other
 
 
Acquired And Internally Developed Finite Lived Intangible Assets [Line Items]
 
 
Finite Lived Intangible Assets, Gross Value
4,462 
4,462 
Finite Lived Intangible Assets, Accumulated Amortization and Impairment
(4,400)
(4,343)
Finite Lived Intangible Assets, Net Value
$ 62 
$ 119 
Goodwill, Purchased Intangibles, and Software Development Costs - Additional Information (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Indefinite Lived Intangible Assets And Internally Developed Software [Line Items]
 
 
 
Purchased indefinite lived intangibles
$ 918,000 
 
$ 918,000 
Capitalized software development costs
$ 3,200,000 
$ 1,200,000 
 
Computer Software, Intangible Asset
 
 
 
Indefinite Lived Intangible Assets And Internally Developed Software [Line Items]
 
 
 
Intangible assets with finite lives, estimated economic lives, years
3 years 
 
 
Goodwill, Purchased Intangibles, and Software Development Costs - Summary of Amortization Expenses (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Goodwill And Intangible Assets Disclosure [Abstract]
 
 
 
 
Amortization of purchased intangibles in revenues
$ 19 
$ 19 
$ 57 
$ 56 
Amortization of purchased intangibles in cost of product revenues
732 
1,248 
2,304 
3,744 
Amortization of purchased intangibles
2,435 
2,487 
7,363 
7,535 
Total amortization expenses of purchased intangibles
$ 3,186 
$ 3,754 
$ 9,724 
$ 11,335 
Goodwill, Purchased Intangibles, and Software Development Costs - Estimated Future Amortization Expense of Purchased Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]
 
 
Remainder of 2014
$ 3,167 
 
2015
10,495 
 
2016
8,484 
 
2017
4,670 
 
2018
 
Total
$ 26,816 
$ 36,540 
Restructuring Costs - Additional Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Restructuring Cost And Reserve [Line Items]
 
 
 
 
Restructuring costs
$ (2,631)
$ 24,887 
$ 36,887 
$ 34,639 
Additions to the reserve
 
 
35,097 
 
Global workforce elimination percentage under restructuring plan
 
 
6.00% 
 
January 2014 Restructuring
 
 
 
 
Restructuring Cost And Reserve [Line Items]
 
 
 
 
Additions to the reserve
 
 
$ 33,100 
 
Restructuring Costs - Summary of Activity of Restructuring Reserves (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Restructuring Reserve [Line Items]
 
Beginning balance
$ 34,929 
Additions to the reserve
35,097 
Interest accretion
1,790 
Non-cash write-offs
(2,576)
Cash payments and other usage
(26,414)
Ending balance
42,826 
Severance / Other
 
Restructuring Reserve [Line Items]
 
Beginning balance
1,143 
Additions to the reserve
11,106 
Cash payments and other usage
(10,790)
Ending balance
1,459 
Facilities
 
Restructuring Reserve [Line Items]
 
Beginning balance
33,786 
Additions to the reserve
23,991 
Interest accretion
1,790 
Non-cash write-offs
(2,576)
Cash payments and other usage
(15,624)
Ending balance
$ 41,367 
Balance Sheet Details - Schedule of Trade Receivables (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Receivables [Abstract]
 
 
Gross accounts receivables
$ 224,871 
$ 225,134 
Returns and related reserves
(40,319)
(38,938)
Allowance for doubtful accounts
(3,105)
(2,827)
Total
$ 181,447 
$ 183,369 
Balance Sheet Details - Schedule of Inventories (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Inventory Disclosure [Abstract]
 
 
Raw materials
$ 2,657 
$ 2,740 
Work in process
1,018 
840 
Finished goods
94,274 
99,729 
Total
$ 97,949 
$ 103,309 
Balance Sheet Details - Prepaid Expenses and Other Current Assets (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
 
 
Non-trade receivables
$ 5,056 
$ 9,251 
Prepaid expenses
42,548 
31,164 
Derivative assets
10,454 
6,748 
Other current assets
5,156 
3,189 
Total
$ 63,214 
$ 50,352 
Balance Sheet Details - Schedule of Deferred Revenues (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
$ 175,307 
$ 172,408 
Long-term deferred revenue
82,101 
87,467 
Service
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
173,367 
170,701 
Long-term deferred revenue
78,495 
83,092 
License
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
1,828 
1,400 
Long-term deferred revenue
3,606 
4,375 
Product
 
 
Deferred Revenue Arrangement [Line Items]
 
 
Short-term deferred revenue
112 
307 
Long-term deferred revenue
$ 0 
$ 0 
Balance Sheet Details - Changes in Deferred Services Revenue (Details) (Software Service Support And Maintenance Arrangement, USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Software Service Support And Maintenance Arrangement
 
 
 
 
Deferred Revenue Arrangement [Line Items]
 
 
 
 
Beginning Balance
$ 252,995 
$ 252,091 
$ 253,793 
$ 241,773 
Additions to deferred service revenue
85,246 
87,993 
255,705 
268,392 
Amortization of deferred service revenue
(86,379)
(86,114)
(257,636)
(256,195)
Ending Balance
$ 251,862 
$ 253,970 
$ 251,862 
$ 253,970 
Balance Sheet Details - Schedule of Other Accrued Liabilities (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Jun. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Dec. 31, 2012
Payables And Accruals [Abstract]
 
 
 
 
 
 
Accrued expenses
$ 27,222 
 
$ 22,515 
 
 
 
Accrued co-op expenses
4,068 
 
4,629 
 
 
 
Restructuring reserves
15,344 
 
11,238 
 
 
 
Warranty obligations
10,766 
10,350 
9,475 
9,711 
9,686 
10,475 
Derivative liabilities
5,262 
 
6,780 
 
 
 
Employee stock purchase plan withholdings
5,129 
 
10,883 
 
 
 
Other accrued liabilities
10,688 
 
12,224 
 
 
 
Total
$ 78,479 
 
$ 77,744 
 
 
 
Balance Sheet Details - Changes in Warranty Obligation (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Guarantees [Abstract]
 
 
 
 
Beginning Balance
$ 10,350 
$ 9,686 
$ 9,475 
$ 10,475 
Accruals for warranties issued during the period
3,846 
4,295 
11,977 
12,407 
Actual charges against warranty reserve during the period
(3,430)
(4,270)
(10,686)
(13,171)
Ending Balance
$ 10,766 
$ 9,711 
$ 10,766 
$ 9,711 
Commitments and Contingencies - Additional Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Commitments And Contingencies Disclosure [Abstract]
 
 
Litigation reserves and payments
$ 3,130 
$ 3,130 
Litigation reserves
$ 750 
$ 750 
Debt - Additional Information (Details) (USD $)
0 Months Ended 9 Months Ended
Sep. 13, 2013
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Debt Instrument [Line Items]
 
 
 
 
Term loan
$ 250,000,000 
 
 
$ 250,000,000 
Maturity date of term loan
Sep. 13, 2018 
 
 
 
Term loan quarterly installments
 
1,600,000 
 
 
Term loan payable period
 
Interest is due and payable in arrears quarterly for loans bearing interest at the base rate and at the end of an interest period (or at each three month interval in the case of loans with interest periods greater than three months) in the case of loans bearing interest at the reserve adjusted LIBOR rate. 
 
 
Debt issuance costs
 
2,700,000 
 
 
Default interest rate applicable for any overdue principal
 
2.00% 
 
 
Default interest rate for base rate loans for any other overdue amounts
 
2.00% 
 
 
Weighted average interest rate
 
1.99% 
 
 
Accrued interest on Term loan
 
100,000 
 
 
Term loan, current
 
6,250,000 
6,250,000 
 
Long-term debt
 
$ 237,500,000 
$ 242,188,000 
 
Base Rate |
Minimum
 
 
 
 
Debt Instrument [Line Items]
 
 
 
 
Term loan interest rate, applicable margin
0.50% 
 
 
 
Base Rate |
Maximum
 
 
 
 
Debt Instrument [Line Items]
 
 
 
 
Term loan interest rate, applicable margin
1.00% 
 
 
 
LIBOR rate plus |
Minimum
 
 
 
 
Debt Instrument [Line Items]
 
 
 
 
Term loan interest rate, applicable margin
1.50% 
 
 
 
LIBOR rate plus |
Maximum
 
 
 
 
Debt Instrument [Line Items]
 
 
 
 
Term loan interest rate, applicable margin
2.00% 
 
 
 
Debt - Interest Expenses Recognized (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Debt Disclosure [Abstract]
 
 
 
 
Contractual interest expense
$ 1,233 
$ 305 
$ 3,687 
$ 305 
Amortization of debt issuance costs
133 
52 
400 
52 
Total
$ 1,366 
$ 357 
$ 4,087 
$ 357 
Investments - Additional Information (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Dec. 31, 2012
Investments Debt And Equity Securities [Abstract]
 
 
 
 
Cash and cash equivalents
$ 406,323,000 
$ 392,629,000 
$ 712,694,000 
$ 477,073,000 
Long-term investments, contractual maturity period, minimum
1 year 
 
 
 
Long-term investments, contractual maturity period, maximum
2 years 
 
 
 
Cost of investment in private company
$ 2,000,000 
$ 2,000,000 
 
 
Investments - Short-Term and Long-Term Investments in Debt Securities (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Schedule Of Available For Sale Securities [Line Items]
 
 
Short-term investments
$ 151,069 
$ 134,684 
Long-term investments
85,599 
56,372 
Short-term Investments
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
151,026 
134,634 
Unrealized Gains
67 
57 
Unrealized Losses
(24)
(7)
Short-term investments
151,069 
134,684 
Short-term Investments |
U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
28,888 
19,792 
Unrealized Gains
23 
Short-term investments
28,911 
19,801 
Short-term Investments |
U.S. Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
39,246 
38,388 
Unrealized Gains
19 
16 
Unrealized Losses
(1)
(3)
Short-term investments
39,264 
38,401 
Short-term Investments |
Non-U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
6,804 
13,734 
Unrealized Gains
10 
Short-term investments
6,808 
13,744 
Short-term Investments |
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
76,088 
62,720 
Unrealized Gains
21 
22 
Unrealized Losses
(23)
(4)
Short-term investments
76,086 
62,738 
Long Term Investments
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
85,630 
56,336 
Unrealized Gains
23 
39 
Unrealized Losses
(54)
(3)
Long-term investments
85,599 
56,372 
Long Term Investments |
U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
28,544 
12,252 
Unrealized Gains
14 
Unrealized Losses
(2)
 
Long-term investments
28,556 
12,260 
Long Term Investments |
U.S. Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
30,664 
30,627 
Unrealized Gains
12 
Unrealized Losses
(28)
(3)
Long-term investments
30,641 
30,636 
Long Term Investments |
Non-U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
 
2,305 
Unrealized Gains
 
Long-term investments
 
2,309 
Long Term Investments |
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Cost Basis
26,422 
11,152 
Unrealized Gains
15 
Unrealized Losses
(24)
 
Long-term investments
$ 26,402 
$ 11,167 
Investments - Schedule of Investment in Unrealized Loss Position (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
$ 80,104 
$ 15,370 
Gross Unrealized Losses, Less than 12 Months
(78)
(9)
Fair Value, 12 Months or Greater
 
1,504 
Gross Unrealized Losses, 12 Months or Greater
 
(1)
Total Fair Value
80,104 
16,874 
Total Gross Unrealized Losses
(78)
(10)
U.S. Government Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
5,478 
 
Gross Unrealized Losses, Less than 12 Months
(2)
 
Total Fair Value
5,478 
 
Total Gross Unrealized Losses
(2)
 
U.S. Government Agency Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
19,964 
5,533 
Gross Unrealized Losses, Less than 12 Months
(29)
(6)
Total Fair Value
19,964 
5,533 
Total Gross Unrealized Losses
(29)
(6)
Corporate Debt Securities
 
 
Schedule Of Available For Sale Securities [Line Items]
 
 
Fair Value, Less than 12 Months
54,662 
9,837 
Gross Unrealized Losses, Less than 12 Months
(47)
(3)
Fair Value, 12 Months or Greater
 
1,504 
Gross Unrealized Losses, 12 Months or Greater
 
(1)
Total Fair Value
54,662 
11,341 
Total Gross Unrealized Losses
$ (47)
$ (4)
Fair Value Measurements - Additional Information (Details) (USD $)
In Millions, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Fair Value Disclosures [Abstract]
 
 
U.S. Treasury and other government agencies percentage of fixed income available-for-sale securities
51.00% 
 
Corporate bonds percentage of fixed income available-for-sale securities
31.00% 
 
Commercial paper percentage of available-for-sale securities
13.00% 
 
Non-U.S. Government securities percentage of available-for-sale securities
3.00% 
 
Money market funds percentage of available-for-sale securities
2.00% 
 
Cash equivalents included in available-for-sale securities
$ 15.3 
 
Fair value of Term Loan
$ 235.5 
$ 247.5 
Fair Value Measurements - Schedule of Fair Value of Marketable Securities and Foreign Currency Contracts (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
$ 251,969 1
$ 211,151 1
Foreign currency forward contracts, Assets
10,454 2
6,748 2
Foreign currency forward contracts, Liabilities
5,262 3
6,780 3
Quoted Prices in Active Markets for Identical Assets, Level 1
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
6,052 1
17,596 1
Significant Other Observable Inputs, Level 2
 
 
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
 
 
Fixed income available-for-sale securities
245,917 1
193,555 1
Foreign currency forward contracts, Assets
10,454 2
6,748 2
Foreign currency forward contracts, Liabilities
$ 5,262 3
$ 6,780 3
Foreign Currency Derivatives - Notional Position by Currency of Outstanding Non-designated Hedges (Details) (Not Designated as Hedging Instrument)
In Thousands, unless otherwise specified
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Brazilian Real
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Brazilian Real
BRL
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Chinese Yuan
CNY
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Israeli Shekel
ILS
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Japanese Yen
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Japanese Yen
JPY (¥)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Mexican Peso
USD ($)
Sep. 30, 2014
Buy
Original Maturities of 360 Days or Less
Mexican Peso
MXN ($)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
USD ($)
Sep. 30, 2014
Buy
Original Maturities of Greater than 360 Days
Israeli Shekel
ILS
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Brazilian Real
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Brazilian Real
BRL
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Chinese Yuan
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Chinese Yuan
CNY
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
British Pound
GBP (£)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Israeli Shekel
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Israeli Shekel
ILS
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Japanese Yen
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Japanese Yen
JPY (¥)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Mexican Peso
USD ($)
Sep. 30, 2014
Sell
Original Maturities of 360 Days or Less
Mexican Peso
MXN ($)
Sep. 30, 2014
Sell
Original Maturities of Greater than 360 Days
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Sell
Original Maturities of Greater than 360 Days
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
USD ($)
Sep. 30, 2014
Sell
Original Maturities of Greater than 360 Days
British Pound
GBP (£)
Derivative [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notional amount of foreign currency
$ 4,287 
 10,508 
$ 21,457 
 132,129 
$ 27,031 
€ 21,287 
$ 36,504 
£ 22,223 
$ 4,923 
 18,043 
$ 4,694 
¥ 514,868 
$ 1,052 
$ 14,129 
$ 8,629 
€ 6,400 
$ 10,551 
£ 6,600 
$ 8,706 
 30,900 
$ 8,487 
 19,975 
$ 20,724 
 128,938 
$ 65,702 
€ 50,325 
$ 31,426 
£ 19,126 
$ 11,305 
 41,125 
$ 8,745 
¥ 930,002 
$ 1,861 
$ 24,673 
$ 28,043 
€ 20,800 
$ 12,469 
£ 7,800 
Foreign Currency Derivatives - Effect of Non-Designated Hedges in Condensed Consolidated Statements of Operations (Details) (Interest and other income (expense), net, USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Interest and other income (expense), net
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Amount of Gain or (Loss) Recognized in Income on Derivative
$ 3,991 
$ (1,783)
$ 4,290 
$ (182)
Foreign Currency Derivatives - Additional Information (Details)
9 Months Ended
Sep. 30, 2014
Derivative Instruments And Hedging Activities Disclosure [Abstract]
 
Maximum duration of foreign exchange forward contracts designated as cash flow hedges
13 months 
Foreign Currency Derivatives - Notional Position by Currency of Outstanding Cash Flow Hedges (Details) (Cash Flow Hedging, Original Maturities of 360 Days or Less)
In Thousands, unless otherwise specified
Sep. 30, 2014
Buy
Chinese Yuan
USD ($)
Sep. 30, 2014
Buy
Chinese Yuan
CNY
Sep. 30, 2014
Buy
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Buy
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Buy
British Pound
USD ($)
Sep. 30, 2014
Buy
British Pound
GBP (£)
Sep. 30, 2014
Buy
Israeli Shekel
USD ($)
Sep. 30, 2014
Buy
Israeli Shekel
ILS
Sep. 30, 2014
Sell
Euro Member Countries, Euro
USD ($)
Sep. 30, 2014
Sell
Euro Member Countries, Euro
EUR (€)
Sep. 30, 2014
Sell
British Pound
USD ($)
Sep. 30, 2014
Sell
British Pound
GBP (£)
Derivative [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
Notional amount of foreign currency
$ 18,931 
 119,271 
$ 34,655 
€ 25,966 
$ 34,737 
£ 21,054 
$ 23,359 
 82,564 
$ 83,220 
€ 62,368 
$ 41,308 
£ 25,028 
Foreign Currency Derivatives - Effect of Derivative Instruments Designated as Cash Flow Hedges in Condensed Consolidated Statements of Operations (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Foreign exchange contracts, Gain or (loss) recognized in OCI-effective portion, total
$ 2,573 
$ (570)
$ 2,574 
$ 1,793 
Gain or (loss) reclassified from OCI into income- effective portion, total
1,342 
1,230 
785 
2,356 
Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness Testing
49 1
113 1
(3)1
273 1
Product revenues
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
1,222 
716 
(3,052)
1,190 
Cost of revenues
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
17 
90 
879 
138 
Sales and marketing
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
(60)
34 
1,737 
(73)
Research and development
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
423 
695 
1,075 
General and administrative
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (loss) reclassified from OCI into income- effective portion, total
160 
(33)
526 
26 
Interest and other income (expense), net
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Gain or (Loss) Recognized-Ineffective Portion and Amount Excluded from Effectiveness Testing
49 1
113 1
(3)1
273 1
Foreign exchange contract
 
 
 
 
Derivative Instruments Gain Loss [Line Items]
 
 
 
 
Foreign exchange contracts, Gain or (loss) recognized in OCI-effective portion, total
$ 2,573 
$ (570)
$ 2,574 
$ 1,793 
Effect of Derivative Instruments Designated as Cash Flow Hedges in Condensed Consolidated Statements of Operations (Parenthetical) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Derivative Instruments And Hedging Activities Disclosure [Abstract]
 
 
Unrealized Gain (Loss) in income due to ineffectiveness
$ 0 
$ 0 
Foreign Currency Derivatives - Derivative Instruments Measured at Gross Fair Value as Reflected in Condensed Consolidated Balance Sheets (Details) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Derivatives Fair Value [Line Items]
 
 
Derivative assets
$ 10,454 
$ 6,748 
Derivative liabilities
5,262 
6,780 
Designated as Hedge Instruments
 
 
Derivatives Fair Value [Line Items]
 
 
Derivative assets
5,122 1
4,457 1
Derivative liabilities
3,281 2
4,235 2
Not Designated as Hedging Instrument
 
 
Derivatives Fair Value [Line Items]
 
 
Derivative assets
5,332 1
2,291 1
Derivative liabilities
$ 1,981 2
$ 2,545 2
Foreign Currency Derivatives - Offsetting of Derivative Assets (Details) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Foreign exchange contract
 
 
Offsetting Assets [Line Items]
 
 
Gross Amounts of Recognized Assets
$ 10,454 
$ 6,748 
Gross Amounts of Assets Offset In the Condensed Consolidated Balance Sheets
Net Amounts Of Assets Presented In the Condensed Consolidated Balance Sheets
10,454 
6,748 
Gross Amounts of Assets Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments
(5,259)
(5,643)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral Pledged to Return cash
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Net Amount
$ 5,195 
$ 1,105 
Foreign Currency Derivatives - Offsetting of Derivative Liabilities (Details) (Foreign exchange contract, USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Foreign exchange contract
 
 
Offsetting Liabilities [Line Items]
 
 
Gross Amounts of Recognized Liabilities
$ 5,262 
$ 6,780 
Gross Amounts of Liabilities Offset In the Condensed Consolidated Balance Sheets
Net Amounts Of Liabilities Presented In the Condensed Consolidated Balance Sheets
5,262 
6,780 
Gross Amounts of Liabilities Not Offset in the Condensed Consolidated Balance Sheets, Financial Instruments
(5,259)
(5,643)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Cash Collateral Pledged to Reclaim cash
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets, Net Amount
$ 3 
$ 1,137 
Stockholders' Equity - Share Repurchase Programs - Additional Information (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended 7 Months Ended
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Sep. 13, 2013
Sep. 30, 2014
Stock Repurchase Program
Sep. 30, 2013
Stock Repurchase Program
Sep. 30, 2013
Stock Repurchase Program
Jul. 31, 2014
Stock Repurchase Program
Oct. 30, 2013
Tender Offer
Sep. 30, 2013
Tender Offer
Dec. 4, 2013
Accelerated Share Repurchase Agreements
Dec. 31, 2013
Accelerated Share Repurchase Agreements
Jun. 30, 2014
Accelerated Share Repurchase Agreements
Jun. 30, 2014
Accelerated Share Repurchase Agreements
Share Repurchases Program [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchase of common stock, shares
 
 
 
 
1.9 
1.7 
9.8 
 
27.4 
 
 
8.0 
1.5 
9.5 
Purchase of common stock, value
 
 
 
 
$ 25,000,000 
$ 17,700,000 
$ 102,300,000 
 
$ 285,400,000 
 
$ 114,600,000 
 
 
 
Shares repurchase authorized amount
400,000,000 
 
400,000,000 
 
 
 
 
200,000,000 
 
250,000,000 
 
 
 
 
Share repurchase plan, remaining authorized amount
 
 
 
 
175,000,000 
 
 
 
 
 
 
 
 
 
Percentage of outstanding common stock repurchase
20.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Payments for repurchase of common stock
150,000,000 
35,240,000 
110,816,000 
 
 
 
 
 
 
 
 
114,600,000 
 
 
Term loan
$ 250,000,000 
 
$ 250,000,000 
$ 250,000,000 
 
 
 
 
 
 
 
 
 
 
Cost of shares repurchased
 
 
 
 
 
 
 
 
$ 10.40 
 
 
 
 
 
Tender Offer expiration date
 
 
 
 
 
 
 
 
Oct. 30, 2013 
 
 
 
 
 
Stockholders' Equity - Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
 
 
$ 4,372 
 
Other comprehensive income (loss) before reclassifications
 
 
1,624 
 
Amounts reclassified from accumulated other comprehensive income
 
 
(794)1
 
Net current-period other comprehensive income (loss)
1,360 
(1,623)
830 
92 
Accumulated Other Comprehensive Income (loss) , Ending balance
5,202 
 
5,202 
 
Unrealized Gains and Losses on Cash Flow Hedges
 
 
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
 
 
80 
 
Other comprehensive income (loss) before reclassifications
 
 
2,574 
 
Amounts reclassified from accumulated other comprehensive income
 
 
(785)1
 
Net current-period other comprehensive income (loss)
 
 
1,789 
 
Accumulated Other Comprehensive Income (loss) , Ending balance
1,869 
 
1,869 
 
Unrealized Gains and Losses on Available-for-Sale Securities
 
 
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
 
 
73 
 
Other comprehensive income (loss) before reclassifications
 
 
(43)
 
Amounts reclassified from accumulated other comprehensive income
 
 
(9)1
 
Net current-period other comprehensive income (loss)
 
 
(52)
 
Accumulated Other Comprehensive Income (loss) , Ending balance
21 
 
21 
 
Foreign Currency Translation
 
 
 
 
Accumulated Other Comprehensive Income Loss [Line Items]
 
 
 
 
Accumulated Other Comprehensive Income (Loss), Beginning balance
 
 
4,219 
 
Other comprehensive income (loss) before reclassifications
 
 
(907)
 
Net current-period other comprehensive income (loss)
 
 
(907)
 
Accumulated Other Comprehensive Income (loss) , Ending balance
$ 3,312 
 
$ 3,312 
 
Stock-Based Compensation - Summary and Allocation of Stock-Based Compensation Expense (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Mar. 31, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
$ 14,768 
 
$ 17,202 
$ 34,178 
$ 53,300 
Tax benefit
3,016 
900 
7,960 
6,778 
24,663 
Stock-based compensation expense related to employee equity awards and employee stock purchases, net of tax
11,752 
 
9,242 
27,400 
28,637 
Cost of sales - product
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
668 
 
686 
1,828 
2,252 
Cost of sales - service
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
1,102 
 
1,479 
3,164 
4,600 
Cost of revenues
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
1,770 
 
2,165 
4,992 
6,852 
Sales and marketing
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
4,673 
 
5,889 
10,397 
19,742 
Research and development
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
3,203 
 
3,669 
7,304 
12,578 
General and administrative
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
5,122 
 
5,479 
11,485 
14,128 
Operating Expenses
 
 
 
 
 
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
 
 
 
 
 
Stock-based compensation expense
$ 12,998 
 
$ 15,037 
$ 29,186 
$ 46,448 
Stock-Based Compensation - Stock Options - Additional Information (Details)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
 
 
Stock options granted
Stock-Based Compensation - Performance Shares and Restricted Stock Units - Additional Information (Details) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Performance Shares
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
659,416 
1,373,329 
Weighted average estimated fair value of share granted
$ 13.81 
$ 8.83 
Number of performance periods
3 years 
3 years 
Restricted Stock Units (RSUs)
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
2,847,979 
4,571,571 
Weighted average estimated fair value of share granted
$ 12.96 
$ 10.12 
Restricted Stock Units (RSUs) |
Non Employee Directors
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Shares granted
140,000 
100,000 
Weighted average estimated fair value of share granted
$ 12.87 
$ 11.14 
Stock-Based Compensation - Stock Options and Employee Stock Purchase Plan - Additional Information (Details) (Employee Stock Purchase Plan)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Employee Stock Purchase Plan
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
Number of shares purchased
2,944,069 
2,904,287 
Number of shares approved and available under the Employee Stock Purchase Plan
11,315,067 
 
Stock-Based Compensation - Valuation Assumptions - Additional Information (Details) (USD $)
3 Months Ended 6 Months Ended 0 Months Ended 9 Months Ended
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2014
Employee Stock Purchase Plan
Jun. 30, 2013
Employee Stock Purchase Plan
Aug. 1, 2014
Employee Stock Purchase Plan
Minimum
Feb. 3, 2014
Employee Stock Purchase Plan
Minimum
Aug. 1, 2013
Employee Stock Purchase Plan
Minimum
Feb. 1, 2013
Employee Stock Purchase Plan
Minimum
Aug. 1, 2014
Employee Stock Purchase Plan
Maximum
Feb. 3, 2014
Employee Stock Purchase Plan
Maximum
Aug. 1, 2013
Employee Stock Purchase Plan
Maximum
Feb. 1, 2013
Employee Stock Purchase Plan
Maximum
Sep. 30, 2014
Nonqualified Stock Option Plan And Employee Stock Purchase
Historical Volatility
Sep. 30, 2014
Nonqualified Stock Option Plan And Employee Stock Purchase
Implied Volatility
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Offering period
 
 
 
2 years 
2 years 
 
 
 
 
 
 
 
 
 
 
Weighted average estimated fair value of share granted
 
 
 
 
 
$ 2.80 
$ 2.82 
$ 2.60 
$ 2.93 
$ 4.10 
$ 4.48 
$ 4.06 
$ 4.57 
 
 
Blended volatility
 
 
 
 
 
 
 
 
 
 
 
 
 
50.00% 
50.00% 
Effect of change in forfeiture rate decreased stock compensation expense
 
 
$ 1,800,000 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss decreased due to cumulative effect of changes in forfeiture rates on all unvested awards
 
 
1,400,000 
 
 
 
 
 
 
 
 
 
 
 
 
Loss per share decreased due to cumulative effect of changes in forfeiture rates on all unvested awards
 
 
$ 0.01 
 
 
 
 
 
 
 
 
 
 
 
 
Actual forfeitures of awards granted to former officers
$ 0 
$ 0 
$ 2,100,000 
 
 
 
 
 
 
 
 
 
 
 
 
Stock-Based Compensation - Significant Assumptions Used to Estimate Fair Value of Employee Stock Purchase Plan (Details) (Employee Stock Purchase Plan)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
 
 
Expected volatility, minimum
26.47% 
42.40% 
26.47% 
42.40% 
Risk-free interest rate, minimum
0.05% 
0.08% 
0.05% 
0.08% 
Expected dividends
0.00% 
0.00% 
0.00% 
0.00% 
Expected volatility, maximum
32.18% 
48.89% 
42.11% 
50.55% 
Risk-free interest rate, maximum
0.47% 
0.35% 
0.47% 
0.35% 
Minimum
 
 
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
 
 
Expected life (yrs)
6 months 
6 months 
6 months 
6 months 
Maximum
 
 
 
 
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
 
 
 
 
Expected life (yrs)
2 years 
2 years 
2 years 
2 years 
Net Income Per Share - Reconciliation of Numerator and Denominator of Basic and Diluted Net Income Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
0 Months Ended 3 Months Ended 9 Months Ended
Dec. 4, 2012
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Numerator
 
 
 
 
 
Net income from continuing operations
 
$ 17,011 
$ (23,978)
$ 21,577 
$ (16,566)
Gain from sale of discontinued operations, net of taxes
35,400 
 
 
459 
Net income (loss)
 
$ 17,011 
$ (23,978)
$ 21,577 
$ (16,107)
Denominator
 
 
 
 
 
Weighted average shares outstanding, basic
 
136,606 
170,310 
137,139 
172,644 
Effect of dilutive potential common shares
 
5,570 
 
5,267 
 
Weighted average shares outstanding, diluted
 
142,176 
170,310 
142,406 
172,644 
Basic net income per share
 
 
 
 
 
Net income (loss) per share from continuing operations
 
$ 0.12 
$ (0.14)
$ 0.16 
$ (0.10)
Gain per share from sale of discontinued operations, net of taxes
 
$ 0 
$ 0 
$ 0 
$ 0 
Basic net income (loss) per share
 
$ 0.12 
$ (0.14)
$ 0.16 
$ (0.09)
Diluted net income per share
 
 
 
 
 
Net income (loss) per share from continuing operations
 
$ 0.12 
$ (0.14)
$ 0.15 
$ (0.10)
Gain per share from sale of discontinued operations, net of taxes
 
$ 0 
$ 0 
$ 0 
$ 0 
Diluted net income (loss) per share
 
$ 0.12 
$ (0.14)
$ 0.15 
$ (0.09)
Antidilutive employee stock-based awards, excluded
 
136 
3,682 
288 
3,597 
Business Segment Information - Additional Information (Details)
9 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2014
Location
Sep. 30, 2014
Customer Concentration Risk
Americas
Customer
Sep. 30, 2014
Revenues
Customer Concentration Risk
Americas
Sep. 30, 2013
Revenues
Customer Concentration Risk
Americas
Sep. 30, 2014
Revenues
Customer Concentration Risk
Americas
Sep. 30, 2013
Revenues
Customer Concentration Risk
Americas
Sep. 30, 2014
Accounts Receivable
Customer Concentration Risk
Americas
Dec. 31, 2013
Accounts Receivable
Customer Concentration Risk
Americas
Segment Reporting Information [Line Items]
 
 
 
 
 
 
 
 
Business organized number of geographical theatres (area)
 
 
 
 
 
 
 
Concentration percentage from customer
 
 
26.00% 
17.00% 
17.00% 
17.00% 
19.00% 
11.00% 
Number of customers accounted for more than 10% of gross accounts receivable and revenues
 
 
 
 
 
 
 
Business Segment Information - Financial Information by Reportable Segment (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenue
$ 335,686 
$ 336,461 
$ 996,229 
$ 1,020,447 
 
% of total revenue
100.00% 
100.00% 
100.00% 
100.00% 
 
Contribution margin
139,644 
134,274 
416,566 
409,943 
 
% of segment revenue
42.00% 
40.00% 
42.00% 
40.00% 
 
Gross accounts receivable
224,871 
 
224,871 
 
225,134 
% of total gross accounts receivable
100.00% 
 
100.00% 
 
100.00% 
Americas
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenue
166,354 
177,285 
497,229 
523,895 
 
% of total revenue
50.00% 
53.00% 
50.00% 
52.00% 
 
Contribution margin
66,993 
69,899 
206,121 
207,876 
 
% of segment revenue
40.00% 
39.00% 
41.00% 
40.00% 
 
Gross accounts receivable
100,424 
 
100,424 
 
86,243 
% of total gross accounts receivable
45.00% 
 
45.00% 
 
38.00% 
EMEA
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenue
83,995 
80,015 
256,099 
248,834 
 
% of total revenue
25.00% 
24.00% 
26.00% 
24.00% 
 
Contribution margin
36,686 
34,094 
109,460 
103,703 
 
% of segment revenue
44.00% 
43.00% 
43.00% 
42.00% 
 
Gross accounts receivable
63,557 
 
63,557 
 
71,970 
% of total gross accounts receivable
28.00% 
 
28.00% 
 
32.00% 
APAC
 
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
 
Revenue
85,337 
79,161 
242,901 
247,718 
 
% of total revenue
25.00% 
23.00% 
24.00% 
24.00% 
 
Contribution margin
35,965 
30,281 
100,985 
98,364 
 
% of segment revenue
42.00% 
38.00% 
42.00% 
40.00% 
 
Gross accounts receivable
$ 60,890 
 
$ 60,890 
 
$ 66,921 
% of total gross accounts receivable
27.00% 
 
27.00% 
 
30.00% 
Business Segment Information - Reconciliation of Segment Information to Consolidated Totals (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Segment Reporting [Abstract]
 
 
 
 
Segment contribution margin
$ 139,644 
$ 134,274 
$ 416,566 
$ 409,943 
Corporate and unallocated costs
(101,993)
(110,640)
(307,931)
(323,645)
Stock-based compensation
(14,768)
(17,202)
(34,178)
(53,300)
Effect of stock-based compensation cost on warranty expense
(204)
(120)
(410)
(421)
Amortization of purchased intangibles
(3,167)
(3,735)
(9,667)
(11,279)
Restructuring costs
2,631 
(24,887)
(36,887)
(34,639)
Litigation reserves and payments
(3,130)
 
(3,130)
 
Transaction-related costs
 
(39)
(156)
(3,411)
Interest and other income (expense), net
(185)
(1,634)
(2,576)
(2,777)
Income (loss) from continuing operations before provision for (benefit from) income taxes
$ 18,828 
$ (23,983)
$ 21,631 
$ (19,529)
Business Segment Information - Revenues by Groups of Similar Products and Services (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Entity Wide Information Revenue From External Customer [Line Items]
 
 
 
 
Net Revenues
$ 335,686 
$ 336,461 
$ 996,229 
$ 1,020,447 
UC Group Systems
 
 
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
 
 
Net Revenues
217,256 
221,370 
649,076 
686,795 
UC Personal Devices
 
 
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
 
 
Net Revenues
60,113 
56,920 
170,226 
157,014 
UC Platform
 
 
 
 
Entity Wide Information Revenue From External Customer [Line Items]
 
 
 
 
Net Revenues
$ 58,317 
$ 58,171 
$ 176,927 
$ 176,638 
Income Taxes - Income Tax Expense (Benefit) from Continuing Operations and Effective Tax Rates (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Tax Disclosure [Abstract]
 
 
 
 
Income tax expense (benefit) from continuing operations
$ 1,817 
$ (5)
$ 54 
$ (2,963)
Effective tax rate
9.70% 
0.02% 
0.20% 
15.20% 
Income Taxes - Additional Information (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Mar. 31, 2014
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Income Tax Disclosure [Abstract]
 
 
 
 
 
 
 
 
U.S federal statutory rate
35.00% 
 
35.00% 
 
 
35.00% 
35.00% 
 
Discrete tax benefits realized on disqualifying dispositions of stock
$ 700,000 
 
$ 500,000 
 
 
$ 2,200,000 
$ 1,500,000 
 
Stock-based compensation expense adjustments related to certain terminated employees
3,016,000 
900,000 
7,960,000 
 
 
6,778,000 
24,663,000 
 
Reinstatement of the federal research and development tax credit
 
 
 
 
2,200,000 
 
 
 
Non-deductible acquisition related expenses
 
 
 
1,000,000 
 
 
 
 
Tax benefit related to the expiration of certain statutes
800,000 
 
 
 
 
 
 
 
Tax benefit related to the expiration of certain statutes
 
 
2,000,000 
 
 
 
 
 
Unrecognized tax benefits
21,300,000 
 
 
 
 
21,300,000 
 
 
Accrued interest and penalties related to uncertain tax positions
1,600,000 
 
 
 
 
1,600,000 
 
1,500,000 
Anticipated reduction in uncertain tax positions
$ 600,000 
 
 
 
 
$ 600,000